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The chemistry of steroids is a matter of great interest because of their immense use 
in research and industry owing to their broad spectrum of biologically and 
pharmacological activities. The earlier work from our laboratories had described the 
preparation of hetero steroids mainly in the cholestane and stigmastane series. In 
continuation, the thesis embodies the preparation of some new steroidal derivatives 
as well as some known compounds prepared by use of new and more convenient 
methods. The structures compounds obtained during the work reported here are 
characterized / identified on the basis of chemical and spectral properties and 
comparison with authentic sample wherever aplicable. The results are summarized 
in the following chapters. 
(0 
Chapter One 
Microwave assisted synthesis of steroidal benzothiazepines 
Benzothiazepines are important group of heterocyclic compounds having attained 
much significance in recent years due to wide range of pharmacological properties. 
In the last decade a number of steroidal benzothiazepines derivative were prepared 
which are known as good biologically active compounds. Our laboratories also 
reported the synthesis of some steroidal benzothiazepines. The survey of the 
literature revealed that some fruitful attempts have been made in the field of 
microwave irradiation for steroidal modifications. Therefoi'e- in continuation with 
our interest in the preparation of steroidal benzothiazepines, we carried out the 
reaction of some easily accessible a,P-unsaturated steroidal ketones such as 
3P-acetoxycholest-5-en-7-one (I) and its analogues 3p-chlorochoIest-5-en-7-one (II) 
cholesta-3,5-diene-7one (III) and cholest-5-en-7one (IV) with 2-aminothiophenol 
(VI) and DMF under microwave irradiation, This afforded 5(x-choicstan-[5,7-bc]-
2',3'-dihydro-r,5'-benzothiazepin-3p-yl acetate (V), 5a-cholestan-[5a,7-bc]-2',3'-
dihydro-r,5'-benzothiazepin-3p-yl chloride (VI) 5a-cholestan-[3a,5-bc]-2',3',4',5'-
tetrahydro-r,5'-benzothiazepin-7-one (VII) and 5a-cholestan-[5,7-bc]-2',3'-dihy-
dro-r,5'-benzothiazepine (VIII) as single compound respectively in fair yield. The 
structures of these benzothiazepine steroids are confirmed on the basis of 
chemical, analytical and spectral (IR, 'HNMR) and Mass spectrometry analysis 
and comparison with authentic samples. This procedure comes out to be better and 
ecofriendly as compared to the previously reported methods. 
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Chapter Two 
Steroidal Indole 
The synthesis of indoles is a very active field due to their wide spread occurrence in 
nature and their wide ranging biological activities. Indoles and its myriad derivative 
continue to capture the attention of synthetic organic chemists and a large number 
of original of indole ring synthesis. Inevitably they may be used on manufacture of 
pharmaceutical intermediate and in industry. Indoles due to their wide occurrence 
and many fold biological activities shown have attracted the attention of synthetic 
chemists in the past. As a result a number of indoles have been synthesised using 
different methods. But only a few studies have been reported regarding the steroidal 
indoles.In continuation with the synthesis of modified steroids and the fact very 
limited number of steroidal indoles are reported prompted us to prepare some 
steroidal compounds with fused indole ring from easily accessible ketone in the 
cholestan series. The present study includes, the survey of important relevant study 
and attempts to obtained [6,7-b] steroidal derivative. The compounds obtained have 
been characterized on the basis of their elemental analysis and spectral studies. 
3P-Acetoxy-5a-cholestan-6-one(lX) its 3P-chloro (X) and 5a-cholestane-6-one 
(XI) analogues were treated with phenyl hydrazine in glacial acetic acid at reflux 
condition for four hours afforded cholesta-3,6-diene [6,7-b] indole (XII) and its 
3P-chloro-5a-cholestan [6,7-b] indole (XIII) and 5a-cholestan [6,7-b] indole (XIV) 
respectively. 
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Chapter Three 
Steriodal Lactam 
Lactams are particularly important molecules owing to their versatility as synthetic 
intermediate and wide spread occurrence in biologically important compounds. 
During the last decade a number of azasteroids have been synthesized. Here we 
have reported the synthesis of N-hydroxyalky! lactams utilizing the slightly 
modified version of Schmidt reaction as described recently by Aube and co-worker 
where hydrozoic acid had been replaced by hydroxyl alkylazidc. The present study 
describes the reaction of some easily accessible steroidal ketone as 
3P-acetoxycholest-5-en-7-one (XV) and its 3p-chloro (XVI) 3p-hydroxy (XVII) 
analogues and choIest-4-en-3-one (XVIII) on reaction with 2-hydroxy-2-
phenylethylazide in presence of BFs-etherate gave N-2-phenyletheny!-7a-aza-B-
homo-3P-acetoxycholest-5-en-7-one (XIX), N-2-phenylethenyl-7a-aza-B-homo-3P-
chlorocholest-5-en-7-one (XX), N-2-phenylethenyl-7a-aza-B-homo-3p-hydroxy-
cholest-5-en-7-one (XXI) and N-2-phenylethenyl-4-aza-A-homo-cholest-4a-en-3-
one (XXII). The characterization of the compounds is based on spectra! methods 
(IR, ' H N M R spectroscopy analysis) and chemical transformation.' 
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Chapter Four 
Mass spectral studies ofThiazoles 
A survey of literature revealed that no systematic mass spectral study of thiazoles 
has been reported. In the previous chapter we have described the preparation of a 
number of such steroidal compound and our laboratories has reported the mass 
spectral studies reveal class of steroidal compound in the recent past. This prompted 
us to examine the mass spectra of these compounds as an attempt to establish 
spectra structure relationship. The compounds included in the study are 2'-N-
phenyIamino-5a-cholest-6-eno [6,7-d] thiazole (I) 3p-acetoxy-2'-N-phenyIamino-
5a-cholest-6-eno [6,7-d] thiazole (11), 3P-proponoxy-2'-amino-5a-choiest-6-eno 
[6,7-d] thiazole (III), 2'-amino-5a-cholest-6-eno [6,7-d] thazole (IV), sp-acetoxy-
2'-amino-5a-cholest-6-eno [6,7-d] thiazole (V) and 3P-proponoxy-2'-N-phenYl-
amino-5a-cholest-6-eno [6,7-d] thiazole (VI). These compounds are structurally 
very close to each other. It was anticipated that they will follow similar 
fragmentation patterns thus offering a simple and effective method of their 
characterization by mass spectrometry. 
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Summary 
The chemistry of steroids is a matter of great interest because of their immense use 
in research and industry owing to their broad spectrum of biologically and 
pharmacological activities. The earlier work from our laboratories had described the 
preparation of hetero steroids mainly in the cholestane and stigmastane series. In 
continuation, the thesis embodies the preparation of some new steroidal derivatives 
as well as some known compounds prepared by use of new and more convenient 
methods. The structures compounds obtained during the work reported here are 
characterized / identified on the basis of chemical and spectral properties and 
comparison with authentic sample wherever aplicable. The results are summarized 
in the following chapters. 
(0 
Chapter One 
Microwave assisted synthesis of steroidal benzothiazevines 
Benzothiazepines are important group of heterocyclic compounds having attained 
much significance in recent years due to wide range of phamiacological properties. 
In the last decade a number of steroidal benzothiazepines derivative were prepared 
which are known as good biologically active compounds. Our laboratories also 
reported the synthesis of some steroidal benzothiazepines. The survey of the 
literature revealed that some fruitful attempts have been made in the field of 
microwave irradiation for steroidal modifications. Therefore in continuation with 
our interest in the preparation of steroidal benzothiazepines, we carried out the 
reaction of some easily accessible a,[3-unsaturated steroidal ketones such as 
3p-acetoxycholest-5-en-7-one (1) and its analogues 3(3-chlorochol.est-5-en-7-one (II) 
cholesta-3,5-diene-7one (111) and cholest-5-en-7one (IV) with 2-aminothiophenol 
(VI) and DMF under microwave irradiation. This afforded 5a-cholestan-[5,7-bc]-
2',3'-dihydro-l',5'-benzothiazepin-3p-yl acetate (V), 5a-cholestan-[5a,7-bc]-2',3'-
dihydro-r,5'-benzothiazepin-3p-yI chloride (VI) 5a-cholestan-[3a,5-bc]-2',3',4',5'-
tetrahydro-r.5'-benzothiazepin-7-one (Vll) and 5a-cholestan-[5,7-bc]-2',3'-dihy-
dro-r,5'-benzothiazepine (VIII) as single compound respectively in fair yield. The 
structures of these benzothiazepine steroids are confirmed on the basis of 
chemical, analytical and spectral (IR, ' H N M R ) and Mass spectrometry analysis 
and comparison with authentic samples. This procedure comes out to be better and 
ecofriendly as compared to the previously reported methods. 
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Chapter Two 
Steroidal Indole 
The synthesis of indoles is a very active field due to their wide spread occurrence in 
nature and their wide ranging biological activities. Indoles and its myriad derivative 
continue to capture the attention of synthetic organic chemists and a large number 
of original of indole ring synthesis. Inevitably they may be used on manufacture of 
pharmaceutical intermediate and in industry. Indoles due to their wide occurrence 
and many fold biological activities shown have attracted the attention of synthetic 
chemists in the past. As a result a number of indoles have been synthesised using 
different methods. But only a few studies have been reported regarding the steroidal 
indoles.In continuation with the synthesis of modified steroids and the fact very 
limited number of steroidal indoles are reported prompted us to prepare some 
steroidal compounds with fused indole ring from easily accessible ketone in the 
cholestan series. The present study includes, the survey of important relevant study 
and attempts to obtained [6,7-b] steroidal derivative. The compounds obtained have 
been characterized on the basis of their elemental analysis and spectral studies: 
3P-Acetoxy-5a-cholestan-6-one(IX) its 3P-chloro (X) and 5a-cholestane-6-one 
(XI) analogues were treated with phenyl hydrazine in glacial acetic acid at reflux 
condition for four hours afforded cholesta-3,6-diene [6,7-b] indole (XII) and its 
3p-chloro-5a-cholestan [6,7-b] indole (XIII) and 5a-cholestan [6,7-b] indole (XIV) 
respectively. 
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Chapter Three 
Steriodal Lactam 
Lactams are particularly important molecules owing to their versatility as synthetic 
intermediate and wide spread occurrence in biologically important compounds. 
During the last decade a number of azasteroids have been synthesized. Here we 
have reported the synthesis of N-hydroxyalkyl lactams utilizing the slightly 
modified version of Schmidt reaction as described recently by Aube and co-worker 
where hydrozoic acid had been replaced by hydroxyl alkylazide. The present study 
describes the reaction of some easily accessible steroidal ketone as 
3p-acetoxycholest-5-en-7-one (XV) and its 3p-chloro (XVI) 3p-hydroxy (XVII) 
analogues and cholest-4-en-3-one (XVIII) on reaction with 2-hydroxy-2-
phenylethylazide in presence of BFs-etherate gave N-2-phenylethenyl-7a-aza-B-
homo-3P-acetoxycholest-5-en-7-one (XIX), N-2-phenylethenyl-7a-aza-B-homo-3P-
chlorocholest-5-en-7-one (XX), N-2-phenylethenyl-7a-aza-B-homo-3(3-hydroxy-
cholest-5-en-7-one (XXI) and N-2-phenylethenyl-4-aza-A-homo-cholest-4a-en-3-
pne (XXII). The characterization of the compounds is based on spectral methods 
(IR, ' H N M R spectroscopy analysis) and chemical transformation. 
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Chapter Four 
Mass spectral studies ofThiazoles 
A survey of literature revealed that no systematic mass spectral study of thiazoles 
has been reported. In the previous chapter we have described the preparation of a 
number of such steroidal compound and our laboratories has reported the mass 
spectral studies reveal class of steroidal compound in the recent past. This prompted 
us to examine the mass spectra of these compounds as an attempt to establish 
spectra structure relationship. The compounds included in the study are 2'-N-
phenylamino-5a-cholest-6-eno [6,7-d] thiazole (I) 3|3-acetoxy-2'-N-phenylamino-
5a-choiest-6-eno [6,7-d] thiazole (II), 3(3-proponoxy-2'-amino-5a-cholest-6-eno 
[6,7-d] thiazole (111), 2'-amino-5a-cholest-6-eno [6,7-d] thazole (IV), 3p-acetoxy-
2'-amino-5a-cholest-6-eno [6,7-d] thiazole (V) and 3p-proponoxy-2'-N-phenyl-
amino-5a-cholest-6-eno [6,7-d] thiazole (VI). These compounds are structurally 
very close to each other. It was anticipated that they will follow > similar 
fragmentation patterns thus offering a simple and effective method of their 
characterization by mass spectrometry. 
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Introduction 
The lipid fraction obtained from plants animals contains another important 
groups of compounds known as steroids. Steroids are the important 
"biological regulater's" that nearly always show dramatic physiological 
effect when they are administered to living organism. Among these 
importants compounds are male and female sex harmones, adrenocorticol 
hormones, D vitamins, the bile acids, and certain cardiac position. Steroids 
are also derivative of the perhydrocylopentanophenanthrene ring systems. 
The field of steroids has provided a host of interesting problems of isolation 
of the steroid entities from natural sources, their structure elucidation, 
biochemical studies, preparation of many analogues of potential medicinal 
interest and search of suitable method for industrial production on of 
steroids drugs. During this unending process many problems of fundamental 
organic chemical aspects have been successfully solved and many new 
compounds of diverse pharmacological activity and therapeutic interest have 
been discovered. Alauddin and Martin smith''^ and martine-smith and 
sugrue'^ have reviewed biological activities in steroids possing nitrogen 
atom, both of natural and synthetic origin. 
In order to design, synthesize, and evaluate the new steroidal derivatives 
like oxa and azasteriods with useful biological activities, during the last 
decade the major effect of the chemists was directed towards modification in 
the structure of steroids in order to enhances their valuable non-hormonal 
activity and increase selectively certain parameters of biological activity of 
the parent hormones. It also included the study of the activity enhancing 
groups that would confer increased oral activities. 
Our laboratory concerned mainly with the synthesis of organic compounds 
and their identification and characterization by the chemical and spectral 
studies, have been engaged for the last two decades in preparation of 
modified steroids. The synthesis of a large number of oxa and azasteroids 
mainly from cholestane and stigmastanc series, have been reported. 
Backmann rearrangement, schmidt reaction and BaeyerVilligar oxidation 
have been extensively used for these syntheses. The characterization <>' 
these compounds has been achieved by chemical and spectral methc'l^ 
employing I.R.. ' H N M R spectroscopy and mass spectrometry. 
In the present work an attempt has been made to prepare steroidiil 
benzothiazepine derivative, by the reaction of 2-aminothiophenol with sotnc 
easily accessible steroidal unsaturated ketones under microwave irradiation. 
We have also carried out the synthesis of some unknown steroidal indoit"'^ , 
and steroidal lactams from the ketone by reaction with phenylhydrazone or 
by Schmidt reaction respectively. The structure of these products JHC 
established on the basis of spectral and chemical evidences. 
The results are debcribed in the following chapters. 
Chapter One 
Microwave assisted 
Synthesis of steroidal benzothiazepines 
Theoretical 
Many researchers have had probably some previous home experience of the 
microwave action in domestic chemical and physical processes, such as cooking 
and defrosting food, they surely realized the notable rate of the heating''. The 
pioneers of the application of microwave into more canonic system thought that it 
could produce similar effect in assisting the reaction carried out in research 
laboratories. In most cases it was soon evident that reactions were more rapid 
cleaner and with an easier workup of the final material saving a great deal of time. 
Microwave have electromagnetic radiation with frequency range from 300MHz to 
30GHz (1-0.01m wavelength) 2.45GHz (12.3cm wavelength) is a frequency allotted 
by an international commission for domestic or industrial oven. Microwave 
represents a non-ionizing radiation that influence molecular motion such as ion 
migration or dipole rotation but not altering the molecular structure. In 2.45 GHz 
microwave the oscillation of the electric field of the radiation occur is 4.9x10^ times 
per second This technique has been utilized for the synthesis of wide variety of 
organic compounds. Number of publication has increased significantly '^", the main 
reason for this increase include the availability of commercial microwave 
equipment intended for organic chemistry and the development of the solvent free 
technique, which has improved the safety aspects, and mostly due to an increased 
interest in shorter reaction time. For this interest Mingos et aC have given an 
explanation of the underlying theory of microwave dielectric heating. Gedye* and 
Langa et al. ha\e discussed the suggested specific microwave effect, Loupy et al}'^ 
have published a number of reviews on solvent free reaction and Strauss was 
reported organic synthesis in the high temperature aqueous systems". In recent past 
synthesis of heterosteroids have been the major area of research for organic chemist 
owing to their wide spectrum of biological and pharmacological activities. With this 
interest a few papers have appeared recently using this technique for steroidal 
transformation'-''^ respectively. The survey of the literature revealed that little 
attempt seem to have been made in the field of microwave irradiation for steroidal 
modification. Therefore in continuation with our interest in the preparafion of 
steroidal derivative like oxa and azasteroids'* steroidal thiazolethiones and 
steroidal derivative like oxa and azasteroids'^ steroidal thiazolethiones and 
thiazolidinethiones'^ steroids. We describe the use of microwave for the preparation 
of the benzothiazepine. The results are encouraging and this can be taken as a good 
convenient method for such transformation. The use of solvent is also minimized 
which make it more ecofriendly. The chapter gives an account of relevant literature 
survey and the result obtained in our own experiments. 
Interest in seven membered heterocycles, with tliree double bond in the ring has 
sprung up in the last few years in connection with studies of aromaticity, and of the 
compounds of their group. Thiazepines are seven membered hetero cycles having 
nitrogen and sulfur as the hetero atom, there may be l,2-thiazepines,(I) 1,3-
thiazepines (11) 1.4-thiazepines (III) and 1,5-thiazepines (IV) depending upon the 
position of nitrogen and sulphur in the ring system 
.N KJ \ / / 
(I) (11) (111) 
Benzo-annelated compounds of thiazepines called as benzothiazepines eg. (IV) are 
known to exhibit a wide spectrum of pharmacological activities hence it has been of 
great interest for synthetic chemists. 
The survey of the literature reveals that perhaps first benzothiazepine derivative was 
reported by Mills and co-wo'rkers.^° They synthesized 2-phenyl-2.3-dihydro-l,5-
benzothiazepin-4(5H)-one (VII) by the reaction of 2-aminothiophenol (VI) and 
cinnamic acid (V) 
Ph—CH=CH-COOH 
(V) (VI) 
Krapsho et al?^ obtained 2-phenyl-l,5-benezothiazepin-4(5H)-one (IX) by the 
reaction of 2-aminothiophenol(VI) with phenyl propiolic acid (VIII). 
Ph—C=C—COOH 
(VIII) 
(VI) 
Condensation of 2-aminothiophenol hydrochloride and phenyl-1-propenyi ketone 
(X) afforded 2J-dihydro-2-methyl-4-phenyI-l,5-benzothiazepine hydrochloride 
hydrate (XI), which was reduced to 2-methyl-4-phenyl-2,3,4,5-tetrahydro-l,5-
benzothiazepine (XII) by sodium borohydride^^. 
O 
II 
CH3-CH=CH-C-Ph + (VI) 
(X) 
(XI) 
1,5-Benzothiazepines can be prepared by refluxing 2-aminothiophenol (VI) and 
P-piperidinopropiophenone (XIII) in xylene in the presence of HCl. During the 
reaction water was colleted and the mixture was worked-up to give 2,3-dihydro-4-
phenyl-6,7-benezo-l,5-thiazepine (XIV) in 35% yield^^ . 
CH,CHnC—Ph 
I ' " I I 
N . O 
(VI) 
(XIII) 
Beckmann rearrangement of thioxanthone oxime (XV) by polyphosphoric acid gave 
dibenzothiazepin-4-one (XVI) in 38% yield^^ 
Reaction of ethyl 3-phenylgiycidate (XVII) with 2-aminothiophenol (VI) gave 
two product ethyl 2-hydroxy-3-(2-aminophenyIthio)-3-phenyl propionate (XVIII) 
and 2-pheny!-3-hydroxy-2,3-dihydro-I,5-benzothizaepin-4(5H)-one (XIX). This 
compound is useful as tranquilizer'^. 
Ph 
Ph—CH—CH-COOEt 
\ / 
0 
(XVII) 
(VI) 
NH.C'OOEt 
(XVIII) 
(Xl\) 
Kalman et al?^ reported the condensation of 2-aminothiophenol (VI) with 
2-(piperidinomethyl)-cyclohexanone (XX) by refluxing them in xylene and 
obtained the benzothiazepine (XXI). 
O 
CH, (VI) 
(XX) (XXI) 
Michael addition of 2-aiTiinotiiiopiienoi (VI) to an atroponitriie (XXII) proceeded 
exothermally to give a (3-(2-amino-p-chlorophenylthio) hydratorponitriTe (XXIII) 
which on refluxing in ethanol gives 4-amino-3p-chIorophenyl-2,3-dihydro-l,5-
benzothiazepine (XXIV). Similarly 2-aminothiophenol (VI) reacted with an atropic 
acid (XXV) to afford a P-(2-aminophenyIthio) hydratropic (XXVI) cyclization of 
(XXVI) in dicyciophenyl carbodiimide occiired readily to give 3-p-chlorophenyl-
2.3-dihydro-I,5-benzothiazipin-4(5H)-one(XXVII)^^ 
CH, 
CHT' V C — CN + (vn >-
(XXII) 
SCH2 CH-/ V c i 
CN 
NH2'^ 
(XXIU) 
f\ Ci 
NH, 
(XXIV) 
CH, 
II " 
,C—COOH 
+ (VI) 
COOH 
^=*;/' '^NH2 ^ ^ 
— CI 
(XXV) (XXVI) 
(XXVII) 
The benzothiazepine (XXIX) was prepared by condensation of 2-aminothiophenol 
(VI) with 3-dimethylaminomethyl-4-chromanone (XXVIII), which demonstrated 
sedatie and muscle relaxant activity^*. 
,Me 
C H 2 / + (VI) 
O ^ M e 
(XXVIII) 
(XXIX) 
Pyrido [2,3-b] [1,5] thiazepinone (XXXIII) was prepared by the reaction of 
3-aminopyridine-2-thiol (XXX) with P-chloropropionic acid (XXXI) in the 
presence of an alkali metal hydroxide followed by cyclization of resulting acid 
(XXXII) in the presence of dicyclohexyl carbodiimide in solution^^. 
I + CICH2CH, COOH 
-a" N-^ ^SCH2CH2COOH ^N"^  ^s 
(XXX) (XXXI) (XXXII) (XXXIII) 
Levai et al?^ reported the synthesis of 2,3-dihydro-2,4-diphenyl-l,5-benzothia-
zepine (XXXV) by the reaction of 2-aminothiophenol (XVI) with chalcone 
(XXXIV). 
O 
II 
Ph—CH=CH-C—Ph 
(XXVIV) 
(VI) 
(XXXV) 
4-methoxy-6-mercapto-5-aminophyrimidine (XXXVI) with P-bromopropionyl 
chloride gave 4-methoxy-6-mercapto-5-(P-bromopropionamide)-pyrimidine 
(XXVH) which on cyclization provided pyrimido[5,6-b]-l,5-thiazepine-4-one^' 
(XXXVIII). 
NH, 
(XXXVI) 
OMe H 
(XXXVII) 
Schmidt reaction of thioflavanone (XXXIX) afforded 2-phenyl-2,3-dihydro-I,5-
benzothiazepin-4(5H)-one (XL) and 2-phenyl-2,3-dihydro-l,4-benzothiazepin-5 
(4 H)-one^^ (XLI). 
+ 
(XL) (XLI) 
R.A. M ane and D.B. Ingle'''' have synthesised 2-phenyl-4-(4'-methyl-2' 
phenyl aminothiazolo-yl)-2,3-dihydro-l,5-benzothiazepine, (XLIII) from 
the 5-[3'-phenylacrylo]-4-methyI-2-phenylaminothiazole by condensation 
with 2-aminothiophenol (VI) in ethanol in the presence of piperidine, 
followed by cyclization with acetic acid. 
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,Me 
H > ^ c / ^ C -I 
Ph 
II 
O 
CH=C 
(XLH) 
(VI) 
(XLIII) 
Treatment of dicarbethoxy monophenyl ethylene (XLIV) with 2-aminothiophenol 
(VI) afforded (XLV), which was cyclized in the presence of base to provide 
2-phenyl-3-hydroxymethyl-2,3-dihydro-1.5-benzothiazepin-4 (5H)-one'''' (XLVI). 
,COOEt 
Ph-CH=C + (Vi) *-
^ COOEt 
(XLIV) 
Ph 
COOEt 
NHfOOEt 
(XLV) 
Ph 
)—CH20H 
1 O 
H 
(XLVI) 
Benzothiazepine derivative (XLVIII) was obtained in one step by the condensation 
of 2-aminothiophenol (VI) with unsaturated ketone (XLVll) in the presence of 
trifluoro acetic acid 35 
CHPh + (Vi) 
(XLVIl) (XLVlll) 
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2-amlnothiophenol (VI) and ethyl- (3-phenyl glycidate (XLIX) is heated at 150-160° 
for six hours to give 2-phenyl-3-hydroxy-2,3-dihydro-l,5-benzothiazepin-4 (5H) 
one (L)^^ 
Ph—CH-CH-COOEt 
I I OH OH 
(XLIX) 
+ (VI) 
The reaction of 2-(N-alkylamino)-thiophenol (LI) with iTiethyl-4-methoxy 
glycidate (LII) was carried out to give merhyi-2-hydroxy-3-(4-methoxyphenyl)-3-
(2-alkylaminophenylthio)-propionate (LIII) which on hydrolysis, followed by the 
cyclization of the resultant amino acids affored N-substituted benzothiazepine, 2-
(4-methoxyphenyl)-3-hydroxy-5-(2-diethylaminoethyl)-2,3-dihydro-l,5-benzoth-
iazepin-4(5H)-one (LlVa) and 2-(4-methoxyphenyl)-3-hydroxy-5-methyl-2,3-
dihydro-1,5-benzothiazepin-4-(5H)-one (LlVb)^^. 
..^^^^^^ 
(LI) 
R 
(Lla) CH2-CH2-N(Et)2 
(Lib) Me 
OMe 
Mei 
\ / 
(LIII) 
R 
(Lllla) CH2-CH2-N(Et)2 
(Llllb) Me 
H H 
•C—^C-COMe-
O 
(LII) 
(LIVa) 
(LIVb) 
OMe 
(LIV) 
R 
CH2-CH2-N(Et)2 
Me 
12 
Kodomari et al^^ have reported the synthesis of 1,5-benzothiazepine (LVI) in 
solvent free condition from chalcone (LV) and aminothiophenol (VI). 
O 
Ar- ^^A? + 
(LV) 
V ^ N H 2 - R 
(Via) (LVI) 
Dandia et al?'^ reported the synthesis of 8-substituted 2-carboxy-2,3-dihydro-l,5-
benzothiazepine, (LVfff) shown by the foKowing scheme. 
SCHEME-I 
(LVII) 
X SH 
NH2 
(VIb) 
COOH 
(LVIII) 
X = OMe/Me/Cl/Br/F 
Shetgiri and Nayak'*" reported a series of 2-(scubstitutedphenyl)-4-(substituted 
phenyl)-2,3-dihydro-1,5-benzothiazepine (LX) by the condensation of substituted 
chalcones (LXIX) with 2-aminothiophenol (VI). 
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o 
R-
, . -X^c-cH=cH-4^ y - R - + 
" ^ ^ 
(LIX) 
= \ .R" 
^ ^ 
R' 
3 ^ N H 2 
(VIb) 
(LX) 
R = OH /Me /CI 
R' = Me /OH /OMe /NO2 /CI 
R" = OH /OMe /CI /Me 
Dubey et al.^^ reported the synthesis of 4-(I-alkylbenzo[d] imidazolo-2-yI)-2-
phenyI-2,3-dihydro-:l,5-benzothiazepine (LXII), involving the reaction with 
benzimidazole chalcone (LXI) and 2-aminothiophenoI (VI). 
+ (VI) 
(LXI) 
H H 
Isoo et al^' reported the synthesis of 2'-methyI-1'-phenyl-1.2,3,10-tetra- hydro-4H-
pyrazolo [3.4-c][I,5] benzothiazepin-3-one (LXIV) by the ullman reaction of I-
phenyI-2-methyI-3-(2-aminophenyl)thiomethyI-4-bromo-3-pyrazoIin-5-one(LXIII). 
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Ph—N 
Me 
I 
N -
Ph—N 
> O H 
X) 
(Lxnn (LXIV) 
2-Aminothiophenol (VI) when treated with Me2NCH=CH-C = CH (LXV) in 
benzene at 0-5°C to ga\e 2-N,N-dimethylaniino-4-methyl-2,5-dihydro-l,5-benzo-
thiazepine (LXVl/l 
NMe2 
(Me)2N-CH=CH-C=CH •+ (VI) »• 
(LXV) 
Pant et al.'^'^ have synthesized 4-aryl-2-carboxy-2,3-dihydro-l ,5-benzothia-zepine 
(LXVII) by the condensation of 2-aminothiophenol (VI) with a,[3- unsaturated keto 
acid (LXVI) . 
COOH 
(VI) 
(LXVII) (LXVIII) 
2-Aminothiophenol (VI) when heated with p-bromobenzoyl acetone (LXIX) in 
D M S O or pyridine g a \ e 2,3-dihydro-2-hydroxy-2-p-bromophenyl-4-methyl- l ,5-
benzothiazepine'*^ (LXX). 
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Br 
o=c 
CH2 
I 
(VI) 
Me 
(LXX) 
(LXIX) 
4-Methoxy-4'-chlorobenzaiacetophenone (LXXl) on reaction with 2-amino-
thiopiieno! (VI), in toluene gave 4-(p-cliiorophenyI)-2-(p-methoxyphenyl)-2,3-
dihydro-1,5- benzothiazepine "^  (LXXll). 
OMe 
OMe 
CH II C—H (VI) 
0 = 
CI 
(LXXI) 
(LXXII) 
r47 Reddy et al. reported the synthesis of 4. 6-bis (2'-substituted-2',3'-dihydro-l,5-
benzothiazepin-4'-yl) resorcinois(LXXIV) prepared in one step by the reaction of 
dichalcones (LXXIII) with 2-aminothiophenol (VI). 
HO, ^ OH 
(VI) >^ 
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(LXXIV) 
R 
(LXXIVa) 
(LXXIVb) 
(LXXrVc) 
(LXXIVd) 
(LXXIVe) 
(LXXIVf) 
(LXXIVg) 
(LXXIVh) 
(XXXIVi) 
Phenyl 
2-chlorophenyl 
p-chiorophenyi 
p-methoxyphenyl 
3,4-dimcthoxy phenyl 
2,4,5-trimethoxy phenyl 
3,4- methylenedioxy phenyl 
2-furfuryl 
2-thenly 
Jayashree and Darbarwar reported the synthesis of quino [4,3-b] 1,5-
benzothiazepine(LXXVl) by the reaction of l-substituted-4-chloro-3-formyl 
quinoline-2(lH)-one(LXXV) with 2-aminothiophenol (VI). 
CHO 
(VI) 
R = Me/Et/Ph 
(LXXVI) 
1,5-Benzothiazepines (LXXVIII) have been synthesised by microwave promoted 
condensation of 2-aminothiophenol (VI) with various chalcones''^ (LXXVII). 
17 
/==\ ^r \J ' tVI) *-
(LXXVll) 
(LXXVIII) 
R = H / CI /NO2 /OMe /OH / (NMe)2 
First one step photochemical synthesis of 1,5-benzothiazepine was reported by 
Neckers et 0/.^ ° in 1982. They carried out the photocycloaddition reaction of 
2-phenylbenzothiazole (LXXIX) with electron rich alkyne such as ethoxyacetylene 
and 1-ethox)' propyne. Reaction with ethoxyacetylene gave two products, 3-ethoxy-
4-phenyl-1,5-benzothiazepine (LXXX) and 3-ethoxy-2-phenylquinoline (LXXXI) 
in 25% and 13% yield respectively. 
r 
S^ Ph 
(LXXIX) 
hv 
H—C=C—OEt 
N . .Ph 
OEt 
(LXXXI) 
However reaction with 1-ethoxypropyne afforded a mixture of 3-ethoxy-2-
methyl-4-phenyl-1,5-benzothiazepine (LXXXII), 2-ethoxy-3-methyl-4-phenyl-l, 
5-benzothiazepine (LXXXIll), 4-ethoxy-3-methyl-2-pheny-1,5-benzothiazepine 
(LXXXIV) 3-ethoxy-4-methyl-2-phenylquinoline (LXXXV) and 4-ethoxy-3-
methyl -2-phenylquinoiine (LXXXVI). 
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(LXXIX) hv 
Me—C=C—OEt 
OEt 
(LXXXII) 
OEt 
(LXXXIII) (LXXXIV) 
Y*=^OEt 
Me 
(LXXXV) 
Margo.'is et a!.^\ have reported the synthesis of tricych"c thiazepine ring systems. In 
this preparation disodium sulphide reacts with (LXXXVII) displacing the chloro 
group in the 2-position to form the intermediate. Thioether (LXXXVIIa) which was 
generated by exhaustive reduction, followed by direct S-alkylatin with 
2-bromobenzyl bromide. The palladium-catalyzed cycloamination of (LXXXVIIb) 
gave thiazepine (LXXXVIII). 
-CI 
Na2S2 
C i / % ^ ^ N O 
(LXXXVII) 
Cl/^^^^/^NO 
(LXXXVIIa) 
Reduction 
Pd2 (dba)3/P(tBu)3 
Br 
Br 
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.^===^ 
NH2 
(LXXXVIIb) (LXXXVIII) 
Pie et alP have reported the synthesis of benzothiazepines (XCIII) and derivatives 
by S-aikylation using 2-aminobenzhydrols (XCI). The preparation of this shown by 
the following scheme. 
SCHEME-II 
-NHBoc 
(LXXXIX) 
S-^ ^COnCHj 
Reagent and conditions 
(i) t-Buli, RCHO, THF, -78°C 
(ii) Methyl thioglycolate, 50% TFA in CH2CI2 room temp. 
(iii)a) LON aqueous NaOH methanol 
b) EDC. DIEA. DMAP, THF room temp. 
l-ethyl-3-(3-dimethylamino propyl) carbodiimide hydrochloride (EDC) 
N-ethyl-N-(l-methyl ethyl)-2-propanamine (DIEA) 
20 
SCHEME-Ila 
. . ^ ^ ^ 
^ ^ ^ ^ H 
(XCIV) 
^ " ^ ^ H 
(XCVI) 
i) 
iii) 
(XCV) 
(XCVII) 
Reagent and conditions 
(i) mercaptoethanol, TFA room temperature 
(ii) PPhs, CBr3, CH2CI2, room temperature 
(iii)K2C03, DMF 
SCHEME - Hb 
\ ii) 
(XCIX) 
(C) 
21 
Reagent and conditions 
(i) Methyl thioglycolate, TFA room temperature 
(ii)LHMDS,THF,-78''C 
lithium hexamehtyl disilazide (LHMDS) 
A key intermediate with a 4,1-benzothiazepine skeleton, useful for the synthesis of 
potent squalene synthetase (SQS) inhibitors, has been prepared via enzymatic 
resolution providing excellent yield and enantiomeric purity '^'. 
SCHEME-III 
C , ^ ^ ^ N H . 
(CI) (CII) 
(CIII) 
C02H CO-'Bu 
(CIV) (CV) (CVI) 
S ^ COj'Bu 
,/ vi 
O CI 
(CVII) 
CO2H 
(CVIII) (CIX) 
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CO^H •CO2H 
Reagent and conditions 
i) BCI3, CH2CI2, benzene, EtsN, 80%; 
ii) Mercaptoacetic acid, 6N HCI, 100°C, 90%; 
iii) morpho-CDI (CMC metho-p-toluenesulfonate), CH2CI2, 75%; 
iv) LDA. THF, r-butyl bromoacetate, 85%; 
V) K2CO3, MeOH, 65°C, 80%; 
vi) CF3COOH, CH2CI2, 95%; 
vii) H ^ ROH. 80-95% 
A series of the 5-aryl-3,3-dibutyl-7-(dimethyl amino)-I,2-benzothiazepine-4-ol 1,1-
dioxides (CXVII) were prepared and were found to inhibit the apical sodium co-
dependent bile acid transporter (ASBT) for the potential treatment for 
hyperlipidemia, preparation is shown by the following reaction.^'' 
S0,( :i 
Y 
F 
(CXII) 
/ \ ^ N H 2 
. HO X 
Bu Bu 
(CXUI) 
j ^ 
TBDMSO 
THF 86% 
> • 
KNMej 85% 
TBDMSCl 93% 
^ . B u 
hBu 
SO2 
V 
(CXIV ') 
n-Buli 
B (oMe)3 
Pd(PPh3)4 
R' PhCH, CI 
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TBDMSO' 
TBAF/THF 
Swem or SO5 pyridine 
60-70% 
Me,N 
OH 
(CXVII) 
R = H / Me / CHzPh 
Prakash et al.^^ have reported the preparation of 1,5-benzothiazepine (CXIX) by 
the treatment of the a,P-unsaturated carbonyl compounds (CXVIII) with 
o-aminothiaophenol (VI) result in the formation of 1,5-benzothiazepine (CXIX). 
H + (VI) 
(CXIX) 
Ar = Ph / CI C6H4 / Me C6H4 / OH C6H4 / NO2 C6H4 / thienyl / pyridyl 
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Lee et al.^^ have reported a solid phase combinatorial synthesis of benzothiazole 
(CXXIII) and 2,3-dihydro-[l,5]-benzothiazepine derivative (CXXIV) by the 
condensation of Wang resin and Rink amide resin (CXX) in the presence of bis-(2-
nitro-4-carboxyphenyl) disulfide gave (CXXI). The nitro group of (CXXI) was 
reduced to its amine with concomitant cleavage of the disulfide bond using 
SnCl4.2H20 to afford (CXXII). The (CXXIII) treated with TFA by cleavage from 
the resin gave (CXXIII) and (CXXIV) respectively. 
.SH 
O—X-H 
(CXX) 
0-x« ^ x Y ^ 
(CXXI) 
HX 
o 
(CXXIV) 
Reagent and conditions 
i) Bis-(2-nitro-4-carboxyphenyI) disulfide, HOBt, DIC, DMF 
ii) SnCl2, 2H2O, NaOAc, DMF 
iii) RCHO, EtOH 
iv) R 'COCH, CHR^ EtOH, AcOH 
v) 20%, TFA. 
NH2 
(CXXII) 
// 
N 
(CXXIII) 
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Discussion 
The immense chemotherapeutic application of 1,5-benzothiazepine especially that 
of diltiazen in the treatment of ailments of a cardiovascular system such as coronary 
vasodilation^', hypertension^^ etc has been reported. It was found that an important 
number of fluorinated 1,4 and 1,5-benzothiazepines have been introduced as the 
pharmacological and cardiovascular agents, such as fluorodiazepine, triflubazam 
etc. Incorporation of fluorine atom on 1,5-benzothiazepine or analogous nucleus 
enhance pharmacological properties by increasing the solubility in lipid materials 
and fat deposits in the body when compared to their non-fluorinated analogous^^. It 
was found that Cl^°, Me^', CF3" or a free -COOH^^ group when present on different 
position in the 1,5-benzothiazepine nucleus act as potential pharmacophores. A 
series of 1,5-benzothiazepine and 4-fluorophenyl group have been found to be 
effective for the treatment of cancer metastasis^ and also 8-fluoro-1.5-
benzothiazepine is reported to be anti-AIDS agent in the preliminary screening^^. 
Recently Giuliano et af^ have also show the preliminary anti-HIV screening of 
some new tricyclic derivative of 1,5-benzothiazepines (CXXV-CXXXIV). These 
become increasingly interesting since, 1,5-benzothiazepines show antifungal, 
antibacterial^\ antifeedant^^ analgesic^' and anticonvulsant activity™. Despite their 
importance from pharmacological / biological activities'''^" and synthetic point of 
view, only a few methods for the preparation of 1,5-benzothiazepine are reported in 
literature. In addition, 1,5-benzothiazepine are used as starting materials for the 
preparation of fused ring compounds such as triazolo*' and oxadiazolo-
benzodiazepines^^. 
MeO' 
(CXXV) 
MeO. 
(CXXVI) 
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N-
MeO' 
N 
(CXXVII) 
o 
)n 
R 
MeO 
(CXXVIII) 
MeO. X N 
MeO ^ S^ 
(CXXIX) 
p 
)n 
R 
O 
HN f 
MeO^ J^ } ^ ^ ' 
MeO' " ^ ^ S - ^ 
R 
(CXXX) 
Me 
N-
N 
MeO' 
O 
R 
(CXXXI) 
MeO. 
NH, 
R 
)n 
(CXXXII) 
HN-
^OEt 
-Me 
MeO 
N O 
(CXXXIII) 
MeO 
OEt 
N 
-Me 
H P 
N-
(CXXXIV) 
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Owing to the interest in syntlietic steroids and tlie expectations that steroidal 
benzothiazepines would show important biological/ physiological activity. Our 
laboratory has recently reported* '^^ ^ the synthesis of some steroidal 
benzothiozepines. 
The literature survey also reveals that very little attempt has been made for the 
preparation of such derivative under microwave condition^ '^'^ '^''^ '^ '* further that the 
microwave induced conversions would be much more economical and 
ecofriendly we carried out the reaction of 2-aminothiophenol with some easily 
accessible steroidal ketones such as 3(3-acetoxycholest-5-en-7-one (CXXXV) 
3p-chlorocholest-5-en-7-one (CXXXVI) cholesta-3,5-dien-7-one (CXXXVII) 
and cholest-5-en-7-one (CXXXVlll) under microwave irradiation and the 
compounds obtained have been characterized on the basis.of chemical, analytical 
and spectral evidences and with authentic samples wherever possible. 
R 
(CXXXV) AcO 
(CXXXVI) CI 
(CXXXVIII) 
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Reaction of 3B-acetoxycholest-5-en-7-one (CXXXV) with 2-aminothiopehnol 
(VI): 5a-cholestan-r5,7-bc1-2'. 3'-dihvdro -1', S'-benzothiazepin-SB-vl acetate 
(CXXXIX) 
The ketone (CXXXV) and 2-aminothiophenoI were taken in DMF and then acetic 
acid (catalytic amount) was added and the mixture was irradiated under microwave 
5(2+2+1) minutes. The reaction mixture was allowed to attain room temperature 
and treated with cold water. The solid obtained was filtered and dried, 
recrystallization from ethanol afforded a TLC pure compound m.p. 93°. 
CgHn 
CsH,-
AcO AcO 
(CXXXV) 
(CXXXIX) 
Characterization of compound m.p. 93°; 5a-cliolestan-[5J-bcl-2\3'-dihvdro-r., 
5'-benzothiazepin-3B-vl acetate (CXXXIX) 
The elemental analysis of the compound m.p. 93° corresponded to the molecular 
formula C35H51NSO2 suggesting the reagent 2-aminothiophenoI (VI) is 
incorporated. The I.R. spectrum of the compound exhibited bands at 3065, 1645 
(aromatic) 1545 (C=N), 1731 (CH3COO-) and 739 cm"' (C-S). The value suggest 
the presence of 1,5-benzothiazepine moiety fused in steroidal nucleus. The ' H N M R 
spectrum of the compound displayed two multiplets at 5 7.1 and 6.5 ascribable to 
four aromatic protons. Another multiplet at 6 4.5 (W'/2 = 14 Hz) was assigned to 
Cs-aH and A/B ring junction as trans. Multiplet at 6 2.4 integrating for three 
protons was ascribed to C6-H2 and C^-H. A singlet at 5.2.0 integrating for three 
protons is assigned to proton of acetate moiety. Other methyl proton signals were 
obtained at 6 1.1, 0.92, 0.85 and 0.76. The spectral values support the 
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characterization of the compound m.p. 93° as 5a-cholestan-[5,7-bc]-2',3'-dihydro-
l',5'-benzothiazepin -3|3-yl acetate (CXXXIX). 
Reaction of 3B-chIorocholest-S-en-7-one (CXXXVI) with 2-aminothiophenoI 
(VI); 5a-cholestan fSaJ-bcl -2',3'-dihvdro-l',5'-benzothiazepin-3B-vl chloride 
(CXL) 
The ketone (CXXXVI) was allowed to react with 2-an:\inothiophenol (VI) under 
microwave irradiations as described earlier. After the workup the solid obtained was 
filtered and dried. Recrystallization from ethanol afforded a TLC pure compound 
m.p. 225°. 
C8H,7 
CgHiy 
(CXXXVI) 
(CXL) 
Characterization of compound m. p. 225'';5a-cholestan-[5, 7-bc1-2', 3'-dihvdro-
r, 5'-benzothiazepin-3|3-vl chloride (CXL) 
The elemental analysis of the compound corresponding to the molecular formula 
C33H4gNSCl. M~ 525/527 (positive beilstein test). The reagent 2-aminothiophenol 
(VI) is incorporated. I.R. spectrum of the compound showed absorption bands at 
3042 (C-H), 1652 (aromatic), 1582 (C=N). 748 (C-Cl) and 755cm"' (C-S). The 
values suggest the presence of 1,5-benzothiazepine moiety fused in steroidal 
framework. ' H N M R spectrum of the compound showed a broad muftiplet at § 7.1-
6.6, integrating for four hydrogen, which was assigned to aromatic protons Another 
multiple! at 6 3.3 (W'/2=l4Hz) which can easily be assigned to Cj-aH half band 
width suggests this proton to be axial and a-oriented rendering the A/B ring 
junction as trans. A multiplet at 5 2.4, integrating for three protons was ascribable to 
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Cfi-tL and Cs-H. Methyl proton signals were obtained at 61.11, 0.93, 0.83 and 0.70. 
On the basis of the spectral data and "comparison with authentic sample this 
compound mp.225° is identified as 5a-cholestan [5,7-bc]-2',3'-dihydro-l',5'-
benzothiazepine-3P-yl chloride (CXL). 
Reaction of cholseta-3,5-dien-7-one (CXXXVII) with 2-aminothiophenol 
rVI):5a-cholestan-f3a,5-bc1-2',3\4'.5'-tetrahvdro-l',5'-benzothiazepin-7-one 
(CXLI) 
The dienone (CXXXVII) was allowed to react with 2-aminothiophenol (VI) under 
microwave irradiation as described earlier. After the work up atTorded an oil which 
failed to crystallize. The oil was subjected to column chromatography and elution 
with the petrol ether afforded oil (CXLI). TLC showed that it is a single compound 
and hence used as such for characterization. 
CsHp 
CgHn ^ ! 
(CXXXVII) 
(CXLI) 
Characterization of the oil: 5a-cholestan-[3a, 5-bcl-2'3',4'.5'-tetrahvdro-r,5-
benzothiazepin-7-one (CXLI) 
The elemental analysis of the compound corresponded to the molecular formula 
C33H49NSO. The reagent 2-aminothiophenol (VI) is incorporated. I.R. spectrum 
showed absorption bands at 3347 (NH) 3050, 1593 (aromatic). 1700 (C=0) and 
740cm' (C-S). These values suggest the presence of 1,5-benzothiazepine moiety 
fused in steroidal frame work. The ' H N M R spectrum of the compound (CVII) 
showed signals at brm 5 7.2-6.6 (4H aromatic), 6 6.47 (IH, NH). 2.8m (IH, C3-PH 
W'/2=5Hz), 2.2m (3H, C^-ih and Cg-H) along with methyl proton signals at 6 1.27, 
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1.0, 0.9, 0.83 and 0.8. On the basis of spectural data and comparison with authentic 
sample. This compound as an oil is characterized as Sa-cholestan [3a,5-bc]-2', 
3',4',5'-tetrahydro-r,5'- benzothiazepin-7-one (CXLI). 
Reaction of cholest-5-en-7-one (CXXXVIII) with 2-aininothiophenol (VI); 5a-
cholestan-[5.7-bcl-2',3'-dihvdro-l',5'-benzothiazepine(CXLII) 
The ketone (CXXXVIII) was allowed to react with 2-aminothiophenol (VI) under 
microwave irradiation as described earlier. After the work up afforded a solid which 
was crystallized to give compounds m.p. 115° TLC pure compound used for 
characterization. 
I 
CgHiv 
(CXXXVIII) 
(CXLII) 
Characterization of compound m. p. 115°;5a-cholestan-f5,7-bcj-2', 3'-dihydro-
1', 5'-benzothiazepine (CXLII) 
The elemental analysis of the compound corresponded to the molecular formula 
C33H49NS (M* 491). Indicating that the reagent 2-aminothiophenoi (VI) is 
incorporated. I.R. spectrum of the compound showed absoiption bands at 1580cm"' 
(C=N), 760 (C-S), 3060 and 1610 (aromatic). These values suggest that presence of 
1,5-benzothiazepine moiety fused in steroidal framework. ^HNMR spectrum of the 
compound showed a multiplet at 5 6.68-7.3, integrating for four protons (aromatic 
protons). Another multiplet at 5 2.61, integrating for three protons was assigned to 
C6-H2 and C7-H. Methyl proton signals were obtained at 61.2. 0.9, 0.83 and 0.7. 
Therefore, on the basis of sepctural data the comparison with authentic sample this 
compound m.p. 115° is characterized as 5a-cholestan-[5,7-bc]-2',3'-dihydro-r,5'-
benzothiazepine (CXLII). 
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All the melting points were observed on a kofler hot block apparatus and are 
uncorrected. I.R. spectra are obtained in KBr/Nujol with Pye-Unicam SP3-100 
spectrophotometer. I.R. values are given in the cm"'(s-strong m-medium w-weak, 
br-broad). The ' H N M R spectra were run in CDCI3 on Varian A-60 instrument with 
Me4Si as the internal standard and its values are given in ppm (5) (s-singlet 
d-doublet t-triplet dd-double doublet br-broad mc-multiplet centred at). Mass 
spectra were measure on JMS D-300/AIEMS-9. Thin layer chromatographic (TLC) 
plates were coated with silica gel and sprayed with 20% aqueous solution of 
perchloric acid. Silica gel (20g) was used for one gm of the material to be separated 
in column chromatography. Petroleum ether refer to a fraction of boiling point 40-
60°. For the microwave irradiation, domestic microwave oven (National, sharp 
courosel operating at 2450 MHz and lOOOw power as per the manufacturers 
specification) was used at medium power setting. 
33-Acetoxvcholest-5-ene (CXLIII) 
A mixture of cholesterol (lOOg), pyridine (150ml), and freshly distilled acetic 
anhydride (100ml) was heated on awater bath for 2 hours. A light brown solution 
was obtained which after allowing to cool at room temp was poured on to crushed 
jce-with stirring 3p-acetoxycholest-5-ene was obtained as a white precipitate which 
was filtered under suction and washed with water and air-dried. The crude product 
was recrystallized from acetone as needles,m.p 114-115° (reported" m.p 116°). 
3B-Chlorocholest-5-ene fCXLIV) 
Freshly purified thionly chloride (37ml) was added gradually to cholesterol (50g) at 
room temp. A vigorous reaction ensued with the evolution of gaseous product when 
the reaction slackened. The mixture was gently heated at a temp 50-60° on a water 
bath for one hour, and then poured on to crushed ice with stirring. The yellow solid 
thus obtained was filtered under suction and washed several times with ice-cold 
water and air-dried. Recrystallization from acetone gave 3p-chIorocholest-5-ene 
(CX) (47.5g), m.p. 95-96° (reported^^ m.p. 96-97°). 
It gave a positive Beilstein test and a yellow colour with tetranitromethane in 
chloroform. 
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Cholest-5-ene (CXLV) 
3p-Chlorocholest-5-ene (CXLIV) (lOgm) was dissolved in warm amy! alcohol 
(230ml) and sodium metal (20.0g) was added gradually to the solution with the 
continuous stirring over a period of eight hours. During this period of addition of 
sodium, the reaction mixture was warmed occasionally so as to facilitate the 
dissolved, sodium metal. When all the sodium metal was dissolved the reaction 
mixture was poured into water acidified with hydrochloric acid and then allowed to 
stand over night. A white crystatUine solid was obtained which was filtered under 
suction and washed thoroughly with water and air-dried. The crude material was 
recrystallized from acetone to provided the desired compound as cubes (7.5g), m.p. 
94-95° (reported" m.p 89.5-912°). 
3B-Acetoxvcholest-5-en-7-one(CXXXV) 
A solution of t-butylchromate [from t-butylalcohol (60ml), CrOs (20g), acetic acid 
(84) ml and aceticanhydride (10ml)] was added at 0°C to a solution of SP-
acetoxycholest-5-ene (CXLIII) (8g) in carbon tetrachloride (150ml), acetic 
acid(30ml) and acetic anlydride (10ml). The mixture was heated under reflux for 
three hours and diluted with water. The organic layer was washed successively with 
sodium bicarbate (NjaHCOs) solution (5%) and with water. Evaporation of the . 
solvents under reduced pressure furnished an oil which was crystallized from 
methanol to give the desired ketone (4.0g) (CXXXV), m.p 162° (reported^^ m.p 
162°). 
Reaction of 33-acetoxvcholest-5-en-7-one (CXXXV) with 2-aminothiopehnoi 
(VI); 5a-chotestan-r5,7-bc1-2'.,3'-dihvdro-l',5'-benzothiazepin- 3B-vl acetate 
(CXXXIX) 
The ketone (CXXXV:500mg:1.13mmol) and 2-aminothiophenol (VI:500mg 
:4.76mmol) was taken in DMF (5ml) and glacial acetic acid (catalytic amount) was 
added and the mixture was irradiated under the microwave oven for 5(2+2+1) 
minutes at 2450 MHz and used at medium power setting. The reaction mixture was 
allowed to attain room temperature and treated with cold water. The solid separated 
was filtered, washed with water and air dried. Recrystallization from ethanol, this 
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afforded 5a-cholestan-{5,7-bc]-2',3'-dihydro-l ',5'-benzothiazepin-3P-yl acetate 
(CXXXIX) as solid (42Img: 0.78mmol), m.p. 93°. 
I.R. spectrum : X^^^x 1731 (CH3COO-) 1545 (C=N), 
3060, 1645 (aromatic), 739 cm"' (C-S) 
' H N M R spectrum : 57.1 m and 6.5 m (4H, aromatic protons) 
4.5m(lHC3-aH W'/2 = 17H )^ 
2.4m (3H Ce-H: and Cg-H), 2.0s (3H CH3COO) 
1.1, 0.92, 0.85 and 0.76 (other methyl protons) 
Analysis found : C, 76.9; H; 9.7; N; 2.4 
Calculated for C35H5, NSO2 : C; 76.89; H; 9.59; N; 2.42 
3B-Chlorocholest-5-en-7-one(CXXXVI) 
A solution of t-butyl chromate [From t-butyl alcohol (60 ml), CrOs (20g), acetic 
acid (84 ml) and acetic anhydride (10ml)] was added at 0°C to a solution of 3[3-
chlorocholest-5-ene (8gm) in carbon tetrachloride (150ml) acetic acid (30ml) and 
acetic anhydride (10ml). The reaction mixture was heated under reflux for three 
hours and diluted with water the organic layers was washed successively with 
sodium bicarbonate (NaHCOs) solution (5%) and water dried over anhydrous 
sodium sulphate. Evaporation of the solvent under the reduced pressure furnished 
an oil which was crystallized from methanol to give the ketone (CXXXVI) (3.5g), 
m.p 144° (reported^ 144-145°). 
Reaction of 3P-chlorocholest-5-en-7-one (CXXXVI) with 2-aininothiophenol (VI); 
5a-cholestan-[5a.7-bc1-2,3;dihvdro-r,5'-benzothiazepin-3P-vl chloride (CXL) 
The ketone (CXXXVI:500mg:1.19mmol) and 2-aminothiophenol (VI:500mg 
:4.76mmol) was taken in DMF (5ml) and glacial acetic acid (catalytic amount) 
was added and the mixture was irradiated under the microwave oven for 5(2+2+1) 
minutes at 2450 MHz and used at medium power setting. The reaction m.ixture was 
allowed to attain room temperature and treated with cold water. The solid 
separated was filtered, washed with water and air dried. Recrystallization from 
ethanol afforded 5a-cholestan-[5,7bc]-2',3'-dihydro-1,5'-benzothiazepin-3|3-yl 
chloride (CXL:450mg:0.85mmol), m.p. 225° (reported*^ m.p. 225°). 
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I.R. Spectrum 
' H N M R spectrum 
Analysis found 
C33H48 NSCI requires 
Ama. 3042, 1652 (aromatic) 1582 (C=N) 
755 (C-S), 748 cm'' (C-Cl) 
57.1-6.6 br m(4H aromatic protons) 
3.3m(lHC3-aH W'/2=14H2) 
2.4m (3H, C6-H2 and Cg-H) 
1.11,0.93,0.83 and 0.70 methyl protons 
C 75.3; H, 9.3; N; 2.7 
C. 75.31: H, 9.19: N, 2.66% 
m/z 525/527 
Cholesta-3,5-diene-7-one (CXXXVII) 
To a solution of 3(3-acetoxycholest-5-en-7-one (5g) in ethanol (lOOml) was added 
HCl (5ml 12N). The reaction mixture was heated under reflux for two hours. On 
cooling the dienone (CXXXVII) separated as plates was filtered and recrystallized 
from ethanol (3g), m.p. 116° (reported'" m.p 118°). 
Reaction of cholesta-3,5-diene-7-one (CXXXVII) with 2-aminothiophenol(VI): 
5a-cholestan-[3a,5-bc1-2',3',4',5'-tetrahvdro-l'-5'-benzothiazepin-7-one(CXLI) 
The dienone (CXXXVlI:500mg:1.57mmol) and 2-aminothiophenol (VI:500mg: 
4.76mmol) were taken in DMF (5ml) and glacial acetic acid (catalytic amount) was 
added. The reaction mixture was irradiated under the microwave for 5(2+2+1) 
minutes at 2450 MHz and used at medium power setting. After the work, up, 
afforded an oil which failed to crystallize. The oil was subjected to column 
chromatography and elution with the petrol ether afforded as 5a-cholestan-[3a,5-
bc]-2',3',4',5'-tetrahydro-l ',5'-benzothiazepin-7-one(CXLl) (398mg: 0.78mmol). 
IR spectrum : X^^^ 1700 (C=0), 3050, 1593 (aromatic) 
3347 (N-H) 740cm-' (C-S) 
' H N M R Spectrum : 6 7.2-6.6 br m(4H, aromatic protons) 
6.47(IH, NH), 2.8 (1H, C3-PH W'/2=5H,) 
2.2m (3H, C6-H2 and Cg-H), 1.27, 1.0 
0.9. 0.83, 0.8 (other methyl protons) 
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Analysis found : C; 78.0; H; 9.8; N; 2.7 
Calculated for C33H49NSO : C; 78.05; H; 9.72; N; 2.75% 
ChoLest-5-en-7-one (CXXXVIID 
A solution of t-butyl chromate [from t-butyl alcohol (60ml), CrOs (20g), acetic acid 
(84ml) and acetic anhydride (10ml)] was added at 0° to a solution of cholest-5-ene 
(8g) in carbon tetrachloride (150ml), acetic acid (30ml) and acetic anhydride 
(10ml). The mixture was reflux for three hours and then it diluted with water the 
organic layer was washed successively with sodium bicarbonate (NaHCOa) solution 
(5%) and water, dried over anhydrous sodium sulphate. Evaporation of the solvent 
under reduced pressure furnished an oil which recrystallized from methanol to give 
ketone (CXXXVlll) 2.5g, m.p. 128° (reported^'m.p. 125-129°). 
Reaction of cholestan-5-en-7-one (CXXXVIID with 2-aminothiophenol (VI); 
5a-cliolestan-f5,7-bc1-2',3'-dihvdro-l', 5'-benzothiazepine(CVIII) 
The ketone (CXXXVllI:500mg:1.30mmol) and 2-aminothiophenol (VI: 500mg: 
4.76mmol) were taken in DMF (5ml) and then acetic acid (catalytic amount) was 
added and the mixture was irradiated under the microwave for the 5(2+2+1) 
minutes at 2450 MHz and used at medium power setting. The reaction mixture was 
allowed to attain room temp and treated with cold water the solid obtained was 
filtered and dried. Recrystallization from ethanol afforded a TLC pure compound 
m.p 115° as 5a- cholestan- [5,7-bc]-2',3-dihydro-r,5'-benzothiazepine (CXLII: 
405mg:0.82mmol), m.p 115° (reported*^ m.p. 115°). 
I.R spectrum : 1610 and 3060 (aromatic) 
1580(C=N), 760cm"'(C-S) 
' H N M R spectrum : 6 7.3-6.6 m(4H, aromatic protons) 
5 2.61 m (3H, Ce-Hj and Cg-H) 
Analysis found 
Calculated for C33 H49NS 
M" 
i.2, 0.9, 0.83 and 0.7 (other methyl protons) 
C, 80.6:H, 10.0 ;N, 2.8 
C, 80.59; H. 10.64; N, 2.84% 
m/z491 
37 
References 
1. M, Alauddin and M.M. Smith; / . Pharnu London., 14, 325 (1962). 
2. M. Alauddin and M.M. Smith; Ibid., U, 469 (1962). 
3. M.M. Smith and M.F. Sugrue; Ibid., 16, 569 (1964). 
4. A. Fini and A. Breccia; P«re opp/. cAcw., IX, 573 (1999). 
5. S.C2Ad\ck\ Tetrahedron., 5i, 10403 (1995). 
6. P.Lidstrom, J.Tiemey, B.Wathey and J.Western; Tetrhedron., 57, 9225 
(2001). 
7. C. Gabriel, S. Gabriel, E.H. Grant, B.S.J. Halstead and D.M.P. Mingos; 
Chem. Soc. Rev., 27, 213 (1998). 
8. R.N. Gedye and J.B. Wei; Can. J. Chem., 76, 525 (1998). 
9. F.Langa, P.D. Cruz, P.D. Hoz, A.D. Ortiz and E.D. Barra; Contemp. Org. 
Synth., 4, 373 (1997). 
10. A. Loupy, A. Petit, J. Hamelin, F. T. Boullet, P. Jacquault and D. Mathe; 
Synthesis., 1213 (1998). 
11. C.R. Strauss; ^«5/.J.C/iem., 52, 83 (1999). 
12. B. DaylandN.H. Ertel;//p/d:, 33, 333 (1990). 
13. P. Marwah, A. Marwah and H.A. Lardy; Tetrahedron., 59, 2273 (2003). 
14. F.R. Skoda, P. Peter, J. Horvath, Z. Tuba and L. Kollar; Steroids., 67, 709 
(2002). 
15. P.S. Kiuru and K. Wahala; Steroids., 21, 54 (2006). 
16. A. Spinella, T. Fortunati and A. Soriente; Synlett., 93, (1997). 
17. M.G.C. Kahn, E. Konde, F. Dossou, D.C. Labaree, R.B. Hochberg and R.M. 
Hoyte; Bioorg. Med. Chem. Lett, 16, 3454 (2006). 
18. P. Goswami, S. Hazarika, A.M. Das and P. Chaudhary; Ind. J. Chem., 43B, 
1275 (2004). 
38 
19. S.M. Ali, D. Clarke, G.R. Cliff and G.A. Morrison; / . Chenu Research., 
352 (1990). 
20. W.H. Mills and J.B. Whitworth; / . Chenu Soc, 2738 (1927). 
21. J. Krapcho and C.F. Turk; J. Med. Chenu, 9, 191(1966). 
22. C.I. Hsing, S. Chin and C.P.Li; C.A., 66, 28751 (1967). 
23. H. Kalman and H.H. Olga; Acta chinu Acad. Set Hung., 56(4), 405 (1968). 
24. N. Rasanu; C.A., 11, 38937q (1969). 
25. H. Kugita, H. Inoue, M. Ikezaki and S.Takeo; Chem. Pharm. Bull., 11(10), 
2028 (1970). 
26. H. Kalman, H. Olga, M. Gyula, V. Ferenc and F. Emil; C.A., 72, 55532s 
(1970). 
27. J.B. Carr; JHet. Chem., 8(3), 511 (1971). 
28. Serdex Societed', Etudes de Research de diffusion etd' Exploitation Fr. 
Demonde; CA, 79, 78859n (1973). 
29. N.l. Traven, T.S. Safonova and Znaki; 5i(19) 77 (1974); C.A., U, 105592v 
(1974). 
30. A. Levai and R. Bongar; Acta. Chem. Budapesp., 88, 293 (1976); C.A., 85, 
9433 Ip (1976). 
31. A.F. Karemov, M.P. Nemeryuk, O.L. Apartikova and T.S. Safonova; Khim 
GeterotsikeSoedin., 10, 1332 (1977) C.^., 88, 5082If (1978). 
32. A Leva/; Acta. Cliim. Acad. ScL Hung., 104(4), 385 (1980). 
33. R.A Mane and D.B. ingle; Ind J. Chem., 2VQ, 973 (1982). 
34. I. kihachiro, H. Mtkio, O. Sachio, M. Kiyoshi, K. Kazuo, Y. Hajimu, N. 
Mitsuaki, N. Yoshiki and M. Makato; Ger. Oflfen., 2,905, 637 (CI. C07D 4 
17/06), 16 Aug. 1979 Japan; C.A, 92,2253la (1980). 
35. G. Toth, A Szollosy, A. Levai and H. Duddeck; Org. Magnreson., 20(3), 
133 (1982); CA, 98, 89335g (1983). 
39 
36. K. Hiroshi, I. Hirosumi and I. Munekatsu; C.A., 73,25547d. (1970). 
37. H. Kugita, H. Inoue, M. Ikezaki, M. Konda and S. Takeo; Chem. Pharm. 
Bull, 19(3), 595 (1971). 
38. M. Kodomari, T. Noguchi and T. Aoyama; Synthetic Communication., 
34(10), 1783 (2004). 
39. A. Dandia, M. Sati, and A. Loupy; Green Chemistry., 4, 599 (2002). 
40. N.P. Shetgiri and B.K. Nayak; Ind. J. Chem., 42B, 683 (2003). 
41. P.K. Dubey. A. Naidu, C.R. Kumar and P.V. Prasada Reddy Ind. J. Chem., 
42, 1701 (2003). 
42. I. Isoo, U. Taisci and O.Noriichi; Chem. Pharm. Bull., 18(10), 2058 (1970). 
43. A.A. Petrov. l.A. Maretina, E.A. Sokolova, Otknytiya and Izobert; 47(81), 
(1984) C.A., 102, 203990V (1985). 
44. U.C. Pant, B.S. Gaur and M. Chugh; Ind. J. Chem., 268, 947 (1987). 
45. U.C. Pant, B.S. Gaur and V. Kumar; Ind. J. Chem. Soc, 680 (1986). 
46. U.C. Pant, B.S. Gaur and M. Chugh; Ind. J. Chem., 189 (1988). 
47. R. Jayasima Reddy, D. Ashok and P.N. Sharma; Ind. J. Chem, 32B, 404 
(1993). 
48. A. Jayashree and M. Darbarwar; Ind. J. Chem., 32B, 1963 (1993). 
49. V.M Patel and K.R. Desai; Ind. J. Chem., 43B, 199 (2004). 
50. M. Sindler. Kulyk and D.C. Neckers; J.O.C, 47, 4915 (1982). 
51. B.J. Margolis. J.J. Swidorski, and B.N. Rogers; J.O.C, 68, 644 (2003). 
52. Y. Pei, M.J. Lilly, D.J. Owen, L.J. Dsouza, X.Q. Tang, J. Yu, R. Nazarbaghi, 
A. Hunter, CM. Anderson, S. Glasco, N.J.Ede, I.W. James, Uday, Maitra, S. 
Chandrasekaran, W.H. Moos and S.S.Ghosh;/.O.C, 68, 92 (2003). 
53. X. Yang, L. Buzon, E. Hamanaka and K. Kevin. C. Liu; Tetrahedron: 
Asymmetry., U. 4447 (2000). 
40 
54. M.B. Tollefson, S.A. Kolodziej, T.R. Fletcher, W.F. Vernier, J.A. Beaudry, 
B.T. Keller and D.B. Reitz; Bioorg. Med, Chenu Lett, Jl, 3727 (2003). 
55. O. Prakash, A. Kumar, A. Sadana, R. Prakash, S.P. Singh, R.M. Claramunt, 
D. Sanz, I. Alkorta and J. Elguero; Tetrahedron., 61, 6642 (2005). 
56. C.L. Lee, Y. Lam and S.Y. Lee; Tetrahedron Letter., 42, 109 (2001). 
57. K. Weiss, P. Fitscha, A. Gazso, D. Gludovaz and H. Sinzinger; Prog. Clin, 
Biol, Res., 301, 353 (1989); C.A., H I , 70642v. (1989). 
58. M. Takeda, A. Oishi, H. Nakajima and T. Nagao; (Tanabe Seiyaku Co. Ltd.) 
Jpn. Kokai Tokyo Koho J.P., 61, 1986,103, 828 (86, 103828) (CI A61 k 
31/55), 1986, Appl. 84/225, 030. 1984; C.A.. 105 183965x(1986). 
59. R. Filler; Client. Tech., 4, 752 (1974). 
60. A. Lochead, J.C. Muller, C. Denys and H, Dumes; Eur. Pat AppL EP., 338, 
892 1989(ClC07D281/10),FRAppI., 85/5, 131, 1988; C.A, 112, 158278m 
(1990). 
61. K.S. Atwal, S.Z. Ahmed, D.M. Floyd, S. Moreland and A. Hedberg; Bioorg. 
Med. Chenu Lett, 3, 2797 (1993). 
62. D.M. Floyd, S.D. Kimball, J. Krapcho, J. Das, C.F. Tusk. R.V. Mosquin, 
M.N. Lago, K.J. Duff, V.G. Lee and R.E. White; J. Med Chem., 35(4), 
756 (1992). 
63. Y. Inada, M. Tanabe, K.ltoh, H. Sugihara and K. Nibhikawa; Jpn., 
J. Pltarmocol., 48(3), 323 (1988); C.A., HO, 539x (1989). 
64. N.K. Ahmad; Can. Pat Appl., C.A., 2030, 159 (C1.A61K31 /55), \99\: US 
Appl., 441, 083, (1989); C.A., 115, 198515f (1991). 
65. M.Upreti, S.Pant, A.Dandia and U.C.Pant; Phosphorus, Sulphur Silicon., 
113. 165(1996). 
66. G. Grandolini, L. Peridi and V. Ambrogi; Eur. J. Med. Client, 34, 701 
(1999). 
67. R.A. Mane and D.B. Ingle; Ind J. Chenu, 21B, 973 (1982). 
41 
68. R.J. Reddy, D. Ashok and P.N. Sarma; Ind. J. Client., 32B, 404 (1993). 
69. K. Satyanarayana and M.N.A. Rao; Ind. J. Pharnt. ScL, 55, 230, (1993). 
70. G.D. Sarro, A. Chemirri, A.D. Sarro, R. Gitto and M. Zappala; Eur. J. Med. 
Chem., 30, 925 (1995). 
71. M.C. Aversa, A. Ferlazzo, P. Giannetto and F.H. Kohnke; Synthesis., 230 
(1986). 
72. A. Chimirri, S. Grasso, R. Ottana, Remeo and G.M. Zappala; J. Het. Chem., 
27. 371 (1990). 
73. M. Kaburaki, H. Yabana, H. Doi, K. Nagata, H. Narita and S. Murata; 
Pharmacology., 288(3), 1167 (1999). 
74. A. Garofalo, G. Balconi, M. Botta, F. Corelli, M.D. Incalci, G. Fabrizi, I. 
Fiorini, D. Lamba and V. Nacci; Eur. J. Med Chem., 28, 213 (1993). 
75. A. Garofalo, G. Campiani, S.M. Ciani, I. Fiorini and V. Nacci; 
Tetrahedron., 52, 7745 (1996). 
76. V. Ambrogi, G. Grandolini, L. Giusti. A. Lucachini and C. Martini; Eur. J. 
Med, Chem., 30, 429 (1995). 
77. V. Ambrogi. A. Furlani, G. Grandolini, A. Papaioannou, L. Perioli, V. 
' Scarria and L. Tutobello; Eur. J. Med. Chem., 28, 659 (1993). 
78. G. Campiani, V. Naui, I. Fionni, MP. Fillippis, A. Garofalo, S.M. Ciane, 
G. Greco, E. Novellino, C. Manzonic and T. Mennini; Eur. J. Med Chem., 
32, 241 (1997). 
79. G.D. Sarro, A. Chimirri, A.D. Sarro. R. Gilto, S.Grasso and M. Zappala; 
Eur. J. Med Chem., 30, 925 (1995). 
80. G. Grandolini, V. Ambrogi and C. Rossi; Eur. J. Med. Chem., 25, 87 
(1990). 
81. V. Ambrogi, G. Grandolini, L. Perioli, G.M.D. Mia, M. Ricci and L. 
Tuttehdlo; Eur. J. Med. Chem., 26. 835 (1991). 
82. U. Kugita and M. Chikada; Japan 72,00072 (1972) C.A., 85854y. (1972). 
42 
83. J. Krapcho John and U.S. Pat; 3,3.61,750 (1968). CA., 36196g (1968). 
84. M. Mushfiq and N. Iqbal; / . Chem. Research., 274 (1987). 
85. M. Mushfiq and Geetesh Mudgal; Ind. J. Chem., 27B, 173 (1988). 
86. M. Mushfiq and Geetesh Mudgal; / . Chem. Research(s)., 168 (1992). 
87. M. Mushfiq and Geetesh Mudgal; / . Chem Research., 784 (1992). 
88. C.E. Anagnostopoulos and L.F. fieser; /. Am. Chem. Soc, 76, 532 (1954). 
89. Nadeem Iqbal; Ph.D. thesis., A.M.U., Aligarh (1987). 
90. R.H. Baker and E.N. squire; / . Am Chem Soc, 70, 1487 (1984). 
91. L.F. Fieser, M. Fieser and R.F. Chaskaravarti; / . Am. Chem Soc, 71, 2226 
(1949). 
92. A.H. Milbum and E.W. Truter; / . Chem. Soc, 1736 (1956). 
43 
Chapter Two 
Steroidal Indole 
Theoretical 
Indoles are aromatic heterocyclic organic compounds having a bicyclic structure, 
consisting of six membered benzene ring fused to a five membered nitrogen-
containing ring. Participation of the nitrogen lone pair in the aromatic ring means 
that indole is not a base and it does not behave like a simple amine. Indoles are a 
large family of natural and synthetic compounds with wide ranging biological 
activities the biological activities of indole has been reviewed of Baeyers'. Indoles 
may be used in the manufacture of pharmaceutical intermediate in alkaloids 
synthesis. The first reported indole ring synthesis has given by Emil Fischer^ in 
1883 by the condensation of ketone with phenylhydrazine in presence of lewis acid. 
Indole and its derivative continue to capture the attention of synthetic chemists and 
as a result large number of original indole ring synthesis have been reported. 
Wamhoff et al? and Ban et al.'^ have reported the synthesis of steroidal indoles in 
the recent past. Robinson^ has given a good account of indoles and mechanism of 
their formations. 
This chapter deals with some important and recent studies regarding the indole 
synthesis. Fischer et al^ have reported the indole synthesis in 1883 by the 
condensation of ketone (I) with phenylhydrazine (11) in the presence of Lewis acid 
afforded indole (III) as a resultant product. 
R, + 
O 
(I) 
N-NH2 
H 
(II) 
H^  
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Mechanisms: 
N-NH2 
H 
,N H 
Protonation 
H ^1 
R2 
double imine 
R' 
-^Q 
R" 
,MH, 
ene-hydrazine 
tautomenzation 
[3,3] - Sigmatropic rearrangement 
R-: - NH, 
Sugasawa et alJ have reported the synthesis of indole and the preparation involved 
specific orthochloroacetylation of aniline to give 2-amino-a-chloroacetophenone 
(V) followed by reductive cyclization of (V) with sodiumborohydride in refluxing 
dioxin giving intermediate a-ch!oromethylbenzyl alcohol (VI) which gives indole 
(VII) under basic condition. 
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. ^ ^ ^ 
(IV) 
^NH, 
BCI3/RCN 
AJCU * 
X 
H 
Aia, 
I 
R 
—I + 
B—CI 
,N 
\f 
*- X-
o 
CH2C a 
(VI) 
(V) 
NaBH. 
i*- X-
^ 
(VII) 
OH 
I 
; H C H 2 C I 
NH, 
base X 
NaOMeorNaHRT 
(VIII) 
H 
X = H / Me / CI / F / Me 
The Fisher indole synthesis of 5a-spirostan-3-one (VIII) with 4-R _C6H4NHNH2 
gave indolospirostenes (X) whereas 5p-spirostan-3-one gave the isomeric indolo-
spirostenes (XI)*. 
£=^. Me R 
NHNH, 
(X) 
(IX) 
R = H/Me/N02 
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Paul A. Wender' and Alan W. White, have reported an efficient synthesis of indole 
derivative in one operation by reaction of organodilithium reagents with vicinal 
dication equivalent. 
O 
Cy°-
(XIII) 
o 
CI 
CH30 
(XIII) 
N 
H 
(XIV) 
N 
H 
(XV) 
Madelung'° have reported the preparation of Indoles from the intramolecular 
cyclization of 2-(acylamino)- toluenes using strong bases. 
NaNHj 
k^N/^R 
H 
(XVI) 
Mechanism: 
H n-Bu- - ^ J 
O 
V^^N 
R 
n-Bu 
H 
J 
(XVII) 
V R 
acidic r^ V ' \ ^ R - H2O 
•^^  JL /^rc work up I 1 />rvo VOH 
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Houlihan et al.^^ have reported a modified Madelung version of indole synthesis, 
involving the intramolecular cyclization of an N-(2-alkylphenyl) alkanamide 
(XVIII) by a strong base at elevated temperature to afford indole (XIX). 
r ^ ^ 1 
»-n 
N " 
H 
21^2 
^CR3 
II 
0 
B s^e ^ r ^ ^ 1 L J 1 L J i 
/ R 2 
^ ^ N ' "R3 
H 
(XVIII) (XIX) 
R2=R3=H/Me/Ph 
Bemier et alJ^ have reported the preparation of 6-hydroxypyrimido[4,5-b] indole 
(XXV) ring which involves the reaction of 1,3-dimethyl-6- chlorouracil (XX) with 
p-methoxyphenylhydrazine (XXI) in presence of sodiumcarbonate. The diamine 
(XXIII) obtained undergo cyclization to give 9H-pyrimido [4,5-b] indole (XXIV) 
on refluxing either in 98% formic acid of dimethyl aniline which on heating at 
200°C with pyridiniumchloride afforded 6-hydroxy pyrimido [4,5-b] indole as a 
resultant product (XXV). 
CI 
_ / 
,0 
< 
OMe 
N-Me + MeO 
N-
Me 0 
(XX) 
\ / 
(XXI) 
NHNH, 
MeO 
(XXIII) (XXiV) (XXV) 
Wender et alP have reported the synthesis of indole (XXVIII) by treatment of 2-
bromoaniline (XXVI) with t-butyllithium (3equiv) and 2-chlorocyclohexanone, 
which afforded amino alcohol (XXVII) as an intermediate. Heating (XXVII) with 
pyrimidine in DMF gave the indole. 
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r^ '^V^ 
Br BuLi 
O 
.CI NH2 
(XXV.) - (XXVM) <™"'> 
Smith et al}'' have given the synthesis of indole ketal (XXXII) according to the 
following scheme-1 
(XXIX) 
(XXXI) 
SCHEME - 1 
LDA.THF 
HMPA,(MeS)2* 
t - BuOCl 
(XXX) 
p-TsOH • H20^ 
MeCN 
(XXXII) 
(XXXIIa) 
R = SMe / H 
The Wender and Bischler indole synthesis have been investigated as potential routes 
to dihydroindenoindole. Thus a Wender reaction between N,2-dilithio-N-
trifluoroacetylaniline (XXXIIl) and 2-bromo-5-methoxy-4,6-dimethyl-indanone 
(XXXIV) affords the corresponding dihydroindeno [1,2-b] indole'^ (XXXVII). 
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(XXXVI) (XXXVII) 
Same authors'^ also report that, in a Bischler reaction between 4-methoxyaniline 
(XXXVIII) and 2-bromoindanone (XXXIX) both 8-methoxydihydroindeno [1,2-b] 
indole (XLIII) and 9-methoxydihydroindeno [2,1-b] indole (XLIV) were formed in 
low yields along with other products (XLV, XLVI). 
MeO, MeO, 
MeO, 
(XLII) 
" W-OMe 
(XLIV) (XLIII) 
(XLV) 
OMe 
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(XLVI) 
OMe 
Maruoka et al}^ have reported regioselective Fischer Indole synthesis mediated by 
organoaluminum amide. In this preparation, diethyl aluminium 2,2,6,6-tetra-
miethylpiperidine (DATMP) reacted with (E)-N-methyl-N-phenylhydrazone of 5-
methyl-3-heptanone (XLVII) to give 3-sec-butyl-2-ethyl-l-methylindole (XLVIII) 
as the sole product. The Z isomer (XLVIIa) affords l,3-dimethyI-2-(2-methyl butyl) 
indole (XLVIIIa) with high regioselectivity under similar reaction conditions. 
Me 
I 
Me 
E (XLVII) 
Me 
Z (XLVIIa) 
EtjAl—N 
(DATMP) 
EtjAI—N 
(DATMP) 
Y Et 
Me 
(XLVIII) 
Me 
N ^CH2 
I I 
Me CH-Me 
I 
CH2 
I 
Me 
(XLVIIIa) 
Gracia et al." have reported the synthesis of (IRS, 5RS,!2SR) 2- Benzyl -12-ethyl-
l,2,3,4,5,6-hexahydro-1.5-methanoazocino[4,3-b]indole (L) by the treatment of 2-
azabicyclo[3.3.1]nonane-7-one (XLIX) with phenylhydrazine (II). 
(XLIX) 
(II) 
(L) 
Ri = Et. R. = H 
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Laxmi Rao and Arya K. Mukerjee'^  have reported the synthesis of indoles by the 
condensation of 3-acetylcoumarin (LI) with phenylhydrazine (II) in ethanol gave 
phenylhydrazone (LII). Further phenylhydrazone(LII) forms 3-(indol-2-yl)coumarin 
on heating with anhyd. zinc chloride. 
0^ Ji (II) 
COMe 
EtOH 
(LI) (LII) (LIII) 
Bonjoch etal}'^ have reported the preparations of cis-l-(chloroacetyl)-
1,2,3,3a,4,9,10,1 Oa-octahydropyrolo [2,3-b]carbazole (LV) and cis-l-(tri-chloro-
acetyl)-l,2,3,3a,4>9,10,i0a-octahydropyrolo[2,3-b]carbazole (LVI), shown by the 
following scheme. 
SCHEME - II 
^^'"^ (LV) (LV.) 
R = COCH2CI /COCCI3 /CHzPh 
X = H / 0 
Murugesan et al?^ have synthesized corresponding diphenyl-1,2,3,4-tetrahydro-y-
carbolines(LVlII) from the phenylhydrazone derivative of 2,6-diphenyl piperdin-4-
one (LVII) by using formic acid as a solvent as well cyclizing agent. 
Ph Ph 
HCOOH NH 
Ph 
R 
(LVII) (LVIII) 
R = H /Me /Et /iPr 
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Atarashi et al?^ have reported that by the treatment of ketone (LIX) with 
phenylhydrazine (II) and borontrifluoride etherate in acetic acid gave the expected 
indole (LX)> 
COzEt C02Et 
O' 
(in 
AcOH 
BF3-etherate 
H 
(LIX) 
H 
(LX) 
Brown et al?^ synthesized 2.3.4,4a,5,6,ll,llb-octahydro-8-isopropyl-lH-benzo[a]-
carbazole (R=Pr') (LXIII) and l,2,3,4,4a,5,6,7-octahydro-l !-isopro-pylbenzo[d]-
carbazole (LXIV) by the treatment of !-deca!one (LXI) with 4-isopropylphenyl-
hydrazine (Ila) mixture of hsdrazone (LXII) is formed which in the presence of 
4-sulfosaIicylic acid cyclise to yield main product indole (LXIII) and indolenine 
(LXIV). 
0 NNHCfiH^Pr' 
Prl 
+ 
NHNH, 
4 - sulfosalicylic acid 
(LXI) (lla) (LXII) 
(LXIII) (LXIV) 
Cheng-yi Chen et al?^ have reported a new and efficient method for indole 
synthesis (LXVII) using a palladium catalyzed annulation between o-iodoaniline 
(LXV) with 5a-cholestan-3-one (LXVI) affording the indolo cholestan (LXVII). 
CgHn CgHn 
NH2 O' 
(LXV) (LXVII) 
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Brown et al?'^ have given the synthesis of some novel 10-Isopropyl-7H-5a-
cholestanone [3,2-b]indole (LXIX). Condensation reaction between 5a-cholestan-3-
one (LXVIII) with 4-isopropylphenylhydrize hydrochloride gave the hydrazone 
which on indolisation in glacial acetic acid using 4-sulfosalicylic acid gave a single 
indole (LXIX). Further 0-methylestrone (LXX) and 3a-hydroxy-5-androstr-17-one 
(LXXI) gave indoles (LXXII) and (LXXIII) respectively. These compounds have 
been observed to act as chain-breaking antioxidant^''. 
CgH sfii? CsHr 
MeO 
(LXVIII) 
(LXX) 
MeO 
(LXXin 
R = Pr7 Bu' 
HO^  
(LXXI) 
HO' 
(LXXIII) 
Wagaw et alP'^^ have reported the synthesis of indole by the treatment of 
hydrazone (LXXIV) with aryl bromide (LXXV) in presence of palladium as 
catalyst. The N-arylhydrazone (LXXVl) obtained on subsequent reaction with 
ketone under acidic conditions afforded resultant product (LXXVII). 
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,NH2 
Ph"^  ^Ph 
(LXXIV) 
Cat Pd/ BINAP TsOH.HjO 
(LXXVin 
(LXXVI) 
Ethyl 2-benzoyIamino-3-(pheny!hydrazone) propanoate derivatives (LXXIX) 
prepared from 4-hydroxymethylene-2-phen)l-5-(4H)-oxazolone (LXXVIII) and 
phenylhydrazine (11) in ethanol was converted to ethyl-3-(benzoylamino)-lH-
indole-2-carboxyIates (LXXX) by heating with polyphosphqjrjc a^gvfi ^i^9p,W?^ I'y 
sodium ethoxide.'^ ^ 
/IT'^^ EtOH 
N • 
OH 
OHC^^^COOEt 
NHCOPh 
NHIiss^-COOEt 
(LXXVIII) 
PPA 
R4 H 
H/CI NHCOPh 
Ri (LXXIX) 
COOEl 
NHCOPh 
(LXXX) 
'28 Gribbie et al. have reported the synthesis of steroidal indole by the treatment of 
the reaction between ketone ester (LXXXl) with 2-chlorophenylhydrazine and 
4-methoxyphenyIhydrazine in acetic acid giving the fused indole ester (LXXXIi) 
and (LXXXIII) respectively in 90% yield. 
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(LXXXI) 
(LXXXI) 
COjMe 
2-chlorophenvlhvdrazine^ 
AcOH 
MeO 
4-methoxyphenylhydraziiif 
AcOH 
'C02Me 
CO2H 
Similarly indoles (LXXXVl-XCI) were obtained from the corresponding ketones 
(LXXXI, LXXXIV and LXXXV)^* as shown below: 
CO,Me 
(11)/AcOH 
Lil/DMF * 
(LXXXVI) 
CO2H 
C02Me 
(II)/AcOH 
Lil/DMF 
CO-,H 
(LXXXV) (LXXXVI!) 
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(LXXXI) 
3-Fluorophenylhydrazine (lie) / AcOH 
C02Me 
(XC) (XCI) 
CO-,H 
Kozimin et al?^ have reported the indolization from ketone (XCII) on reaction with 
phenylhydrazine in presence of sodium bicarbonate, acetic acid and alcohol to give 
a mixture of products (XCIII) and (XCIV). 
MeOaQ 
PhNHNH, HCl 
Na^ COi EtOH - AcOH 
(XCII) 
MeOjC^ 
(XCIII) (XCIV) 
Butkus et al.^° have given the synthesis of chiral rH-spiro[l,3 benzodioxole-2,12'-
(6', 10')] methanocyclooct(b) indole (XCVll) a fused polycyclic structure, derived 
from bicyclo [3.3.1] nonane (XCV). The preparation of mono acetate (XCVI) was 
accomplished by regioselective protection of the carbonyl group at position C-9 in 
diketone (XCV) by a reaction with benzene-1,2-diol. Reaction of the monoacetal 
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(XCVI) with phenylhydrazine in the presence of catalytic amount of hydrochloric 
acid afforded indole derivative (XCVII) in excellent yield^ .^ 
(II) 
(XCVI) (XCVII) 
Barolo et al?^ have reported the synthesis of 2-subsituted Indole (C) by reaction of 
l-halo-2-naphthalen-2-ylamine (XCVllI) with enolate ion of acetophenone (XCIX). 
0-Iodoaniline (CI) with 2-indanone anion (CII) afforded 5,10-dihydroindeno[l,2-b] 
indole (CHI). 
COCH"-
Jw. 
DMSO 
J i ^ _ ^ 
DMSO 
(C) 
(CIII) 
Stoncius et al?^ have reported the Fischer indole synthesis of methanocycloocta 
[l,2-b:5,6-b']-diindole (CVII) from bicycIo[3.3.1]nonane-2,6-dione (CIV) with 
hydrazine (CV) in refluxing ethanol. 
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T"Y° NHNH2 
E'OH , HN 
A \ 
N " " *0 N 
H 
(CIV) (CV) (CVlI) 
The Fischer indole synthesis occur in high yield with one equivalent of the ionic 
liquid cholinechloride 2ZnCl2. Exclusive formation of 2,3-disubstitutedindoIe (CX) 
is observed in the reaction of alkyl methyl ketone (CVllI) with phenylhydrazine (II) 
and the product readily sublime directly from ionic liquid.''"' 
0 
R^CHj-^ . R ' 
X 
R - C H J - ^ - ^ R ' + (II) 
(CVIII) 
N cholinechloride 2ZnCU 
(CIX) H (CX) 
R'=H,R^ = R^  = Me 
Curiel et al.""^ have reported the synthesis of a family of simple indolo [2,3-a] 
carbazoles (CXII-CXV) and demonstrated their ability to recognize and sense 
anions using fluorescence spectroscopy. 
.0 
o 
( I I ) 
(CXI) 
AcOH 
reflux 
(CXII) (CXIII) 
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Yiliang Wu et al?^ have reported indolo[3,2-b]carbazole based thin-film transistor 
with high mobility and stability. Treatment of 1,4-cyclohexanedione (CXVI) with 
phenylhydrazine (II) gave cyclohexane-l,4-dione bis-(phenylhydrazone) (CXVII). 
It is treated with cone sulphuric acid to give indolo [3,2-b]carbazole (CXVIII) 
which reacts with 1 -bromooctane and benzyltriethyl ammonium chloride in DMSO 
to afford 5,11-disubstituted indole (CXIX). 
0 = / \ = o + 2 e q / V-NHNH; *• / \ — > J H - N = / \ = N — N H — / \ 
(CXVI) (II) (CXVII) 
ii) 
(CXVIII) (CXIX) 
R = octyl /4-octylphenyl /4-methylphenyl 
Reagent and conditions 
i) AcOH/ EtOH 50°c 
ii) Cone H2SO4 
iii) (a) I-bromooctane, NaOH, Benzyltriethylammonium chloride DMSO 
(b) I-iodo-4-octyl benzene, 12-crown-6, Cu.1,2- dichlorobenzene 
(c) 4-iodotoluene, 12-crown-6. Cu, 1,2-dichloro benzene. 
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Proposed Mechanism: The conversion of X to (CXIXa) on the basis of such 
conversions reported in literatur.^ 
CsHi? 
NH—NH2 
CsHi? 
CsHi? 
H . N ^ ^ 
NH 
CsHi? CsHi? 
NH3 
H^ 
CsHi? 
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Discussion 
Recent survey of literature on indole shows that it has been used on manufacture 
of pharmaceutical intermediate in alkaloids synthesis^^. Various physiological / 
biological''^'''°activities are influenced by them. These compounds are found to 
posses antitumor"'"''^ antifungal''\ anti-HlV metabolites'''', antibacterial and 
antimycotic"^, antiproliferative"^, anticancer''^ and serotonin activities"^ in 
association with other physiological activities. With this interest a number of 
indole synthesis have appeared in literature as reviewed. Further literature reveals 
that steroidal indoles""''^ '' have also been prepared and show biological activites^". 
The number of such steroidal indoles is not very high in the reported literature and 
our continued interest'*' in the synthesis of modified steroids prompted us to 
prepare some more such derivatives which can be screened for biological 
potentials. The present work deals with the synthesis of steroidal indole from 
easily accessible steroidal ketones such as 3P-aceloxy-5a-cholestan-6-one(CXX) 
3(3-chloro-5a-cholestan-6-one (CXXI) and 5a-cholestan-6-one (CXXII). It is 
indeed gratifying that these indoles are obtained in good yields and the products 
obtained have been characterized on the basis of their physical, chemical and 
spectral studies. 
C g H i T 
R 
(CXX) AcO 
(CXXI) CI 
(CXXII) H 
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Reaction of 3B-acetoxy-5a-cholestan-6-one fCXX) with phenylhydrazine fll) in 
acetic acid; 5a-cholestan-3.6-dienef6,7-bI indole (CXXIII). 
The ketone (CXX) was taken in glacial acetic acid heated to boiling and 
phenylhydrazine was added gradually over a period of 45 minutes with small 
amount of BFa-etherate as catalyst. The reaction mixture was heated under reflux 
for four hours. After the completion of the workup, removal of solvent and elution 
from silica column gave pure compound (CXXIII) as an oil (A) which failed to 
crystallize. 
CgHi7 
AcOH, (II) 
AcO 
BF3- etherate 
Characterization of compound as 5a-cholesta-3,6 diene f6,7-b1 indole (CXXIII) 
The compound oil analysed for C34H49N indicating that the reagent phenylhydrazine 
is incorporated. The IR spectrum of the compound exhibited bands at 1650, I6I8 
and 1640 cm"' indicate the presence of vinylic group, 3061 (C-H stretch aromatic) 
and 3160-3440cm"' (-NH). These values indicated the presence of indole moiety 
attached with steroidal nucleus. On the basis of the mechanism and the IR values 
the compound can be formulated as (CXXIII) this finds support from ' H N M R 
spectrum of the compound which gave peak at 57.5 to 6.8 as multiplets for four 
protons (aromatic), a broad doublet for one proton observed at 57.9-7.7 can be 
assigned to (-NH) proton. A multiple! at 5 3.8 was assigned to Cs-aH (W'/2=16Hz, 
axial), a broad singlet at 52.2 for Cj-aH. Methyl protons were observed at 51.0, 
0.94, 0.85 and 0.76. On the basis of above evidence, the compound can best be 
formulated as 5a-cholesta-3,6-diene- [6,7-b] indole (CXXIII). 
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Reaction of 33-chloro-5a-cholestan-6-one (CXXD with phenylhydrazine (II) in 
acetic acid; 3B-chloro-5a-cholestano [6,7-b1 indole (CXXIV). 
The ketone (CXXI) was treated with phenylhydrazine (II) in the presence of glacial 
acetic acid as described earlier after the completion of the work up, removal of 
solvent and elution from silica column gave pure compound (CXXIV) which also 
failed to crystallize. 
CsHiT 
CgHn 
AcOH, (II) ^ 
BF3- etherate* 
HN. 
(CXXi) (CXXIV) 
Characterization of compound oil (B) as 33-chloro-5a-cholestano f6,7-b] indole 
(CXXIV). 
The compound was analysed for C34H50NCI indicating that the reagent 
phenylhydrazine (II) is incorporated. The I.R. spectrum of the compound exhibited 
band at 3439 (-NH) 1622 (C=C), 3150-3070 (C-H, stretch aromatic). 1645 
(aromatic) and 715 (C-Cl) cm"'. These values indicate the presence of indole 
moiety, attached with steroidal nucleus. On the basis of the mechanism and their 
value the compound can be formulated as (CXXIV) this finds support from ' H N M R 
spectrum of the compound which gave peak at 57.5 to 6.8 as the multiplets for four 
protons (aromatic) A singlet for one proton obser\'ed at 64.7 can be assigned to 
(-NH) proton. A multiplet at 63.8 was assigned to Cj-aH (W'/a = 16Hz axial), a 
singlet at 82.2 for Cs-aH. proton and a singlet at 52.0 for Cg-H proton also obser\'ed. 
/ Other methyl proton^ were observed at 6 1.2, 1.0, 0.97 and 0.85. On the basis of 
above evidences the compound can best be formulated as 3P-chloro-5a-cholestan 
[6,7,-b]indole (CXXIV). 
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Reaction of 5a-cliolestan-6-one (CXXII) with phenvlhydrazine (ID in acetic 
acid: Sa-cholestano f6,7,bl indole (CXXV) 
The ketone (CXXII) was reacted with phenylhydrazine (II) in the presence of acetic 
acid as earlier described. After the completion of the workup, removal of the solvent 
and elution from silica column gave pure compound (CXXIV) as an oil (C) failed to 
crystallize. 
CgHn 
C8H,7 
AcoH. (II) 
BF3- elherate 
(CXXV) 
Characterization of compound oil (C) as 5a-choIestano f6,7-b] indole (CXXV) 
The compound oil (C) was analysed for C34H51N indicating that the reagent 
phenylhydrazine (II) is incorporated. The IR spectrum of the compound exhibited 
band at 3053 (C-H, stretch aromatic), 1609-1592 (C=C aromatic) and 3481cm"' 
(-NH). These values indicates the presence of indole moiety attached with the 
steroidal nucleus. On the basis of the mechanism and the IR values the compound 
can be formulated as (CXXV). This find support from ' H N M R spectrum of the 
compound which gave peak at 57.6, 7.5, 7.3 and 7.1 m (4H aromatic protons). A 
broad singlet for one proton observed at 63.8 can be assigned to (-NH) proton. A 
multiple band at 62.81 assigned to Cj-all proton, and also give a multiple band at 
62.2 (Cg-H). Other methyl protons were observed at 61.1, 60.91, 0.86 and 0.62. On 
the basis of above evidence the compound has been identified as 5a-cholestano 
[6,7-b] indole (CXXV). 
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Wd 
All the melting points are uncorrected infrared spectra (I.R.) were measured in KBr 
with Perkin-Elmer 237 and Unichem SP 300 spectrophotometers. The I.R. value are 
given in cm'' (s-strong m-medium w-weak br-broad). ' H N M R spectra were run in 
CDCI3 on Varian A60 instrument and 'HNMR values were given in ppm (s-singlet 
d-doublet t-triplet b-broad m-muhiplet centred at). IMS as internal standard thin 
layer chromatography plates were coated with silica gel G and developed in an 
iodine chamber light petroleum refers to fraction b.p. 60-80°. 
3B-Chlorocholest-5-ene (CXXVI) 
Freshly purified thionyl chloride (75ml) was added gradually to cholesterol (lOOg) 
at room temperature a vigorous reaction ensued with the evolution gaseous product. 
When the reaction slacked, the reaction mixture was gently heated at the 
temperature of 50-60° on a water'bath for Ihr and than poured on the crushed ice-
water, mixture with stirring. The yellow solid obtained was filtered under suction 
and washed several times with ice-cold water and air dried recrystallization of crude 
product from acetone gave 3P-chlorocholest-S-ene (95.5gm) (CXXVI). m.p. 95-96° 
(reported^° 96-97°). It gave positive Beilstein test and a yellow colour with 
tetraanitromethane in chloroform. 
3B-Acetoxvcholest-5-ene (CXXVII) 
A mixture of cholesterol (50g) pyridine (75ml freshly prepared over KOH) and 
freshly distilled acetic anhydride (50ml) was heated on water bath for two hours. 
The resulting brown solution was poured into crushed ice-water mixture with 
stirring. A light brown solid was obtained which filtered under suction washed with 
water until free from pyridine and air dried. The crude product on recrystallization 
from acetone gave pure 3P-acetoxycholest-5-ene (45.0g) (CXXVII), m.p 112° 
(reported^' m.p 113°). 
ChoIest-5-ene (CXXVIII) 
3p-ChIorocholest-5-ene (15g) was dissolve in warm amyl alcohol (300ml) and 
sodium metals (35.Og) was added in small portion to the solution with continuous 
stirring over a period of eight hours. The reaction mixture was heated now and then 
during the course of reaction in order to keep the sodium metal dissolve the reaction 
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was poured into water acidify with HCl and allowed to stand over night a white 
crystalline solid was obtained which was filtered under suction and washed 
thoroughly with water and air dried recrystallization of the crude materials from 
acetone gave cholest-5-ene in cubes (10.8g) (CXXVIII), m.p. 93° (reported^" m.p. 
89.5-91.2°). 
3l3-Chloro-6-nitrocholest-5-ene(CXXIX) 
To a well stirred mixture of SP-chlorocholest-S-ene (12g) glacial acetic acid (80ml) 
and nitric acid (25ml dl.52) at 20°C was added sodium nitrite (3.0g) gradually. 
After the complete addition of sodium nitrite the mixture was ftirther stirred for Ihr 
the ice-cold water (200 ml) was added and the yellowish solid thus separated was 
filtered and air-dried. The desired product was recrystallized from ethanol as 
needless (9.0g) (CXXIX), m.p. 150-152° (reported^" m.p 149°). 
3p-Acetoxv-6-nitrocholest-5-ene(CXXX) 
To a mixture of 3p-acetoxycholest-5-ene (lO.Og) and a nitric acid (250ml dl.42), 
sodium nitrite (lO.Og) was gradually added over a period of one hour. With 
continuous stirring slight external cooling was also applied during the course of 
reaction and stirring was continued for 2 hours. When a yellow spongy mass 
separated on the surface of the mixture.. The mixture was then diluted with cold 
water (200ml) when a green coloured solution was obtained the whole mass was 
extracted with ether and the ethereal solution was successively washed with water 
and sodium bicarbonate (NaHCOs) solution (5%) untill (the washing attain pink 
colour) and again washed with water and air dried over anhydrous sodium sulphate. 
Removal of the solvent afforded as an oil which was crystallized from methanol 
(7.2g), m.p. 104° (reported^" m.p. 103-104°). 
6-Nitrocholest-5-ene (CXXXI) 
A suspension of finely powdered cholest-5-ene (6.0g) in glacial acetic acid (50ml) 
was vigorously stirred at room temperature and treated slowly with nitric acid 
(15ml, 1.5) followed by the addition of sodium nitrite (3g) over a period of Ihour. 
The reaction mixture was poured into cold water and the yellow product thus 
obtained was extracted with either. The ethereal solution was successively washed 
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with water, sodium bicarbonate (NaHCOs) solution (5%) (until the washing attain 
pink colour) and again washed with water. Removal of the solvent after drying over 
anhydrous sodium sulphate provided as an oil which was crystallized from ethanol 
in leafplets (4.0g), m.p 119-120° (reported^^ m.p 120-121). 
3B-Chloro-5a- cholestan-6-one (CXXI) 
A solution of 3p-chloro-6-nitrochoIest-5ene and glacial acetic acid (240ml) was 
heated just to get a clear solution. To this zinc dust (24g) was added gradually in 
small portion with constant shaking. The suspension was heated under reflux for 
four hours and water (24ml) was added at regular interval during the course of 
reaction. The hot solution was poured into ice-cold water. The organic matter was 
extracted with ether and ethereal solution was washed successively with water, 
sodium bicarbonate (NaHCOs) solution (5%) and again with water and dried over 
sodium sulphate (anhydrous). Evaporation of the solvent furnished the ketone as an 
oil which was crystallized from methanol (8.7g) (CXXI), m.p 128-129° (reported^" 
m.p. 129°). 
33-Acetoxv-5a-Cholestan-6-one(GXX) 
Nitro compound (CXXX) (6.0g) was dissolved in glacial acetic acid (250ml) and 
zinc dust.(12.0) gm was added in small portion with shaking. The suspension was 
heated under reflux for four hours water (12ml) was added during the course of 
reaction. The hot solution was filtered, cool to room temperature and diluted with 
large excess of water. The precipitate thus obtained was taken in ether and ethereal 
solution was washed with water sodium bicarbonate (NaHCOa) solution (10%) 
water and dried over sodium sulphate (anlydrous). Removal of the solvent gave an 
oil which was crystallized from methanol (3.9g) (CXX), m.p. 122° (reported^^ m.p. 
127-128°). 
5a-Cholest-6-one (CXXII) 
6-Nitrocholest-5-ene (CXXXI) (6.0g) was dissolve in glacial acetic acid (200ml) by 
heating and to this solution zinc dust (I2.0g) was added in small portion. After the 
initial exothermic reaction had subsided the suspension was heated under reflux for 
three hours and water (12ml) was added gradually during the course of reaction the 
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solution was then filtered and the residue was washed with two (10ml) portion of 
warm acetic acid. To the filtrate a few ml of water was added till tubidity developed 
and it was allowed to stand overnight at room temperature. The crystalline material 
thus separated was filtered under suction and washed thoroughly with water in order 
to remove zinc acetate. The organic solid was air dried and then recystallized from 
ethanol (3.6g) (CXXII), m.p. 96-90° (reported^^ m.p. 95-96°). 
Reaction of 33-acetoxv-5a-cholesan-6-one (CXX) with phenylhydrazine in 
acetic acid: 5a-choIestano-3,6-dienef6,7-b|indole (CXXIII). 
The ketone (CXX: 300mg: 0.67mmol) was taken in glacial acetic acid (25ml) heat it 
boil and phenlhydrazine (375mg: 2.40mmol) was added gradually with in 45 
minutes. During this period the colour changed fi-om colourless to red. The reaction 
mixture was heated under reflux for four hours with stirring, small amount of BF3-
etherate was added as catalyst. The progress of the reaction was monitored by TLC. 
After the completion of the reaction, the solvent was removed under the reduced 
pressure and the residue thus obtained was extracted with ether. The ethereal layer 
washed with several times with water and sodium bicarbonate (MaHCOj) solution 
(5%) and dried over anhydrous sodium sulphate. Removal of the solvent gave oil 
(A) (250mg: 0.53mmol) (CXXIII) which was chromatographed over silica gel 40 g. 
5a-cholestano-3,6-dienef6,7-b1 indole (CXXIII) 
Elution : Pet. ether: ether (10:1) yield (170mg: 0.36mmol) 
IR : A™xl650, 1618-1640cm"'(C=C-C=C-) 
3061 (C-H stretch aromatic) and 3160-3440cm"' (-NH) 
' H N M R (CDCI3) : 57.5 to 6.8 m (4H aromatic protons), 67.9-7.7 (NH) 
5 3.8 [(IH Cj-aH W'/2=16Hz axial)], 52.2 
br (Cs-aH). 61.0, 0.94, 0.85 and 0.76 (other methyl 
protons). 
Analysis found : C; 83.74, H; 11.63 N; 3.27 
C36H53 NO2 requires : C; 83.9, H; 11.89, N; 3.29% 
On the basis of TLC, IR and ' H N M R values found identical the compound is 
characterized as cholesta-3,6-dien.e[6,7-b] indole (CXXIII). 
Reaction of 3B-chloro-5a-cholestan-6-one (CXXI) with phenylhydrazine in 
acetic acid; 33-chloro-5a-cholestano [6,7-b1 Indole (C!?CXIV) 
3P-Chloro-5a-cholestan-6-one (CXXI:250mg:0.61mmol) was taken in glacial 
acetic (30ml) heat to boil and Phenylhydrazine (300mg: 2.07mmol) was added 
gradually with in 45 minutes. During this period the colour changed from colourless 
to red the reaction mixture was heated under reflux for four hours, with stirring. 
Small amount of BFj-etherate was added as catalyst. The progress of the reaction 
was monitored by TLC. After the completion of the reaction, the solvent was 
removed under reduced pressure and the residue thus obtained was extracted with 
ether. The ethereal layer washed with several times with water and sodium 
bicarbonate (NaHCOs) solution (5%) and dried over anhydrous sodium sulphate 
removal of the solvent gave semi solid (190mg;0.37mmol.) which was chromato-
graphed over silica gel. 
36-Chloro-5a-cholestano f6,7-b] indole (CXXIV) as oil (B) 
Elution •  : Pet ether: ether (15:1) yield (lOOmg: 0.19mmol) 
IR : 3439 (-NH) 1622 (C=C), 3150-3070 (C-H, stretch 
aromatic), 1645 (aromatic) and 715 (C-Cl) cm"' 
'HNMR(CDCl3) : 5 7.5 to 6.8 m(4H aromatic protons), 54.7 s(-NH), 
83.8(3a-HW"^ =16Hz axial), 52.28 m(C5 Protons and 
52.0 for (Cg-protons). 5 0.85, 1.2, 0.97 and 1.0 (other 
methyl protons). 
Analysis found : C; 81.50, H; 10.45, N; 5.72 
C34HS0NCI requires : C; 81.41, H; 10.26, N; 5.43% 
On the basis of TLC, IR and 'HNMR values found identical the compound is 
characterized as 3(3-chloro-5a-cholestano [6,7-b] indole (CXXIV), 
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Reaction of 5a-Cholestan-6-one (CXXII) with phenylhydrazine inacetic acid; 
5a-cholestano r6J-b1 indole (CXXII) 
5a-Cholestan-6-one (CXXII: 350mg: 0.91mmol) was taken in glacial acetic acid 
(30ml) heat to boil and phenylhydrazine (400mg: 2.77mmol) was added gradually 
with in 45 minutes. During this period the colour changed from colourless to red. 
The reaction mixture was heated under reflux for four hours with continue stirring. 
Small amount of BFj-etherate was added as catalyst. The progress of the reaction 
was monitored by TLC After the completion of the reaction, the solvent was 
removed under reduced pressure and the residue thus obtained was extracted with 
ether. The ethereal layer washed with several times with water and sodium 
bicarbonate (NaHCOj) solution (5%) and dried over anhydrous sodium sulphate. 
•Removal of the solvent gave oil (290mg: 0.61mmol) which was chromatographed 
over silica gel. 
5a-Cholestano r6.7-b] indole (CXXV) as oil (C) 
Elution : Pet. ether 
Yield : (1 lOmg: 0.23mmol) 
IR : 3053 (C-H,stretch aromatic), 1609-1592 (C=C aromatic) 
and 3481cm"'(-NH) 
: 57.6, 7.5, 7.3 and 7.1 m(4H aromatic protons), 
53.8 br(-NH), 52.81 m(Cia-H), 52.28 m(C8-H). 
51.1. 0.91, 0.86 and 0.62 (other methyl protons). 
; C; 86.21, H; 10.72, N; 3.13. 
: C; 86.11, H; 10.27, N; 3.11% 
On the basis of TLC, IR and ' H N M R found identical the compound (CXXV) was 
characterized as 5a- cholestano [6,7-b] indole. 
'HNMR(CDCl3) 
Analysis found 
C34H51N requires 
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Chapter Three 
Steroidal Lactam 
Theoretical 
The Beckmann rearrangement and Schmidt reaction are the two most frequently 
employed method for the insertion of nitrogen atom into the steroidal frame worlc. 
Other methods for preparation of such hetero steroids include imide synthesis, 
curtuis and Hofinann rearrangement, total synthesis etc. Photochemical reaction and 
microbiological amidition''^ have also been used for the preparation of diff-
azasteroids analogues. The photochemical rearrangement which usually require 
strongly acidic condition cause serious problems such as low regioselectivity of the 
reaction or decomposition of products^"*. Limitation of Schmidt reaction for the 
synthesis of number of substituted lactams led the scientists to replace hydrazoic 
acid with alkyl azide^''^. In 1991 Aube et o/.''*''^  accomplished intramolecular 
reaction of alkyl azides with ketone under remarkably mild and straight forward 
reaction condition. 
J6 Recent reports of obtaining various N-hydroxy lactam, and our continued interest 
in synthesis steroids prompted us to study the similar reaction with some steroidal 
substrates. This chapter deals with some of the more recent and pertinent examples 
regarding the preparation of lactams and the studies made for preparation of 
N-hydroxy lactams in the cholestane series. 
The Schmidt reaction of 5a-cholestan-3-one (la) and its 5|3-isomer (lb) with sodium 
azide and polyphosporic acid or the Beckmann rearrangement of their oximes (Ic) 
and (Id) afforded the 3-azasteroids (Ila) and (lib)''' respectively. 
CgHn CsH 8"I7 
(I) 
X 
(la) O; 5a-H 
(lb) O; 5P-H 
(Ic) NOH; 5a-H 
(Id) NOH; 5a-H 
HN 
x^ X^ 
(II) 
(lla) 5a-
(Ilb) 5P-
H 
H 
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The photo-Beckmann rearrangement of the oxime (III) gave two isomeric lactams 
(IV) and 3-a2a-A-homo-4a. 4a-dimethyl-5a-cholestan-4-one (V)'^ 
^8^17 
o 
/ \ H 
(IV) (V) 
The Schmidt reaction of 3p-acetoxy-5a-bromochoiestan-6-one (Via) afforded 
3(3-hydroxv-6-aza-B-homo-5a-bromocholestan-7-one (Vila) while 5a-bromo-chol-
estan-6-one (Via) gave the lactams (Vllb) and 7-aza-B-homocholest-4-en-6-one 
(VIII)' ' . 
CgHn CRH, CgHiT 
(VII) (vni) 
X 
(Via) OAc 
(VIb) H 
X 
(Vila) OAc 
(Vllb) H 
Doorenbos and Singh carried out the schmidt reaction of 5a-cholestane-3,6-dione 
(IX) using excess of sodium azide and obtained 3,6-diaza-A,B-bishomo-5a-
cholestane-4.7-dione (X)"". 
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Ahmad and Co-workers^' carried out the schmidt reaction of choIesta-4,6- dien-3-
one (XI) and 6p-bromochoIest-4-en-3-one (XII) and obtained the same product, 
3-aza-A-homo-cholesta-4a, 6-dien-4-one (XIII). 
CgHj? 
(XI) (XII) (xni) 
Cholesta-3,5-dien-7-one (XlVa) gave a single oxime (XlVb) which on the 
Beclcmann rearrangement gave 7a-aza-B-homo-cholesta-3,5-dien-7-one (XV)^ .^ 
?8Hl7 
(XIV) 
QHi? 
X 
(XlVa) O 
(XlVb) NOH 
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Beckmann rearrangement of 26-acetoxyfurost-3,5-20(22)-trien-7-one oxime (XVI) 
furnished the lactam 26-acetoxy-7a-aza-B-homofurost-3,5,20(22)-trien-7-one 
(XVII)^^ 
.OAc 
^OAc 
~NOH 
(XVf) 
The Beckmann rearrangement of 7-oximinodiosgeninacetate (XVIII) afforded 3P-
acetoxy-7a-aza-B-homo-22a-spirost-5-en-7-one (XIX) '^'. 
AcO' 
AcO' 
(XVIII) (XIX) 
Black and Johnstone^^ reported the synthesis of medium sized oxo-lactams (XXII) 
by opening of fused tricyclic oxaziridines (XXI)and nitrones (XXIII). 
(CH2)n (CH2)n 
Me / T / = = \ 
Me -N^ \_—^ 
(XX) 
(XXa) n = 2 
(XXb) n = 1 
Me COsH^ Me 
Me'"'^  Jr\J 
(XXI) 
(XXIa) n=2 
(XXIb) n = 1 
Fe^-
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H O 
(XXII) 
(XXIIa) n = 2 
(XXIIb) n = 1 
Photo rearrangement^^ of hydroxy nitrones (XXIIIa-d) in ethanol by mean of light 
of wavelength 254nm afforded mixture of isomeric oxaziridines (XXIII) which on 
treatment with iron (II) sulphate afforded the keto lactams (XlVa-d). 
OH 
(CH2)n 
hv 
Fe ,2+ 
Ml 
Me-
O J 
:(CH2)n 
N-
H 
(XXIV) 
o 
(XXIIIa) n = 3 
(XXIIIb) n = 4 
(XXIIIc) n = 5 
(XXIIId) n = 6 
(XXIVa) n = 3 
(XXIVb) n = 4 
(XXIVc) n = 5 
(XXIVd) n = 6 
Ishibashi and Ikeda^^ accomplished a novel synthesis of five, six and seven 
membered lactams (XXVI, XXVII, XXVIII, XXXI, XXXII and XXXIII) by alkene 
cyclization of N-alkenyl-a (methyl sulphinyl) acetamide (XXV, XXVa) and N-
alken\l-a-chloro-a- (methylthio)-5-acetamide (XXIX, XXX). 
O O II 
SMe 
MeN 
I 
CH H 
Me ^ H 
(XXV) 
Trifluoro acetic 
anhydride 
> 
CH2CI2 0°C 
o 
MeN 
0 
SMe 
MeN 
SMe 
Me 
(XXVI) 
CH2 
(XXVII) 
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o o 
MeN 'Me 
H 
H Me 
(XXVa) 
MeN 
(XXVIII) 
O 
MeN 
^ ^ 
SMe 
H 
(XXIX) 
SnCL 
CHjCiz Me-N 
SMe 
O 
Me- N 
SMe 
• • • • K / 
CI 
(XXXIa) 
O O 
MeN 
(CH2)2/H 
H H 
(XXX) 
'Me TFAA, CHXl, MeN 
9 OCOCF3 
/ H , 
(XXXII) 
TFAA 
O 
MeN 
SMe 
OCOCF3 
(XXXIII) 
Hoffman and Salvador^^ gave one flask conversion of cyclic ketones to N-methyl 
lactams (XXXV1). They reacted ketone with triethyl orthoformate to generate an 
acetal (XXXIV) which is reacted in situ with N(p-nitrobenzene- suifonyl) 
oxy methyl amine (MeNH-OS02C6H4Ns02). Dealkylation of the resulting 
0-ethylimidate (XXXV) with sodium iodide gave the lactam (XXXVI). 
R O ^ ^ O R 
(XXXIV) 
OR 
H" 
RO 
+ 
MeNHONs 
Me 
I 
NHONs 
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RONsO' 
N-Me N-Me 
(XXXV) (XXXVI) 
R = Me / Et 
This method was considered as versatile and more efficient as compared to other 
methods effecting direct conversion of cyclic ketones with N-substituted lactams. 
(XXXVI). Conversion of cyclopropanes to N-substituted P-lactams by Wesserman's 
carbinol amine method is excellent but this procedure is not adaptable to large riiigb. 
This method is superior to photochemical rearrangement of oxaziridines and 
nitrones as the former requires preparation and isolation of oxaziridines by two step 
procedure followed by photolysis. The Latter require isolation of N-methyl nitrone 
and gives much pooreryield. 
Aube et al?^ have given the TiCl4 mediated reaction of alkyl azides with cyclic 
ketones (XXXVII, XXXIX and XLIl) resulting in formation of the product 
(XXXVIIl. XL and XLI, XLIII and XLIV) respectively: 
(XXXVII) 
N-R 
(XXXVIIl) 
(XXXIX) n-Hex (XL) (XLI) 
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n - Hex 'N-, 
(XLII) 
N-nHex CO 
O 
nHex 
(XLIV) 
Suda et al?"^ reported manganese (III) tetraphenylporphyrin chloride [Mn(tpp)Cl] 
is a new and specific catalyst for stereo and regio-selective rearrangement of 
N-phenyl-spiro oxaziridine (XLV and XLVa) into lactams (XLVI, XLVIa and 
XLVIb). 
Ph-N 
Ph-N 
R' .R-
(XLV) 
P h - N 
Ph-N 
0 R^  
(XLVIa) 
R' =R^  
O 
(XLVI) 
+ P h - N 
R^  
=R =^ H/Me 
R' 
R-
(XLVIb) 
Takacs and Weidener''^  reported the synthesis of pentadienyl substituted lactams (L 
and Lll) by the reaction of pentadienyl trimethylsilane, PDS with N-acyliminium 
ions (XLVII) intermediate and (XLVIla) respectively. 
O 
(XLVH) 
f^  . ^ Li (Et^ BH)^  / - ^ _ ^ BH-i-etherate CH,CU 
THF.-78°C \ / '—^ 
OH '^2C ^ ^ PDS 
(XLVfll) 
(XLIX) 
N - R 
CH, 
(L) 
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0 
(XLVIIa) 
Li (Et, BH)^ 
MeOH. H-" 
0 
I I PDS,CH2Cl2 
-R BFyetherate 
OMe 
(LI) (LII) 
R = CH2Ph/ CH2CH=CHCH20Bz 
Evan and Modi^' described a novel approach to Lactam (LV) via plioto induced 
Schmidt rearrangement of the a-azidotriisopropylsilyl ethers (LIV) which were 
obtained by direct azidonation of the triisopropylsilyl enol ethers(LIII). 
OSiPrj O 
R-
N3. ,0SiPr3 
PPTS^ 
TMSN, R-
hv 
-N 
•*• R -
(LIII) 
OSiPrs 
(LIV) 
X-
(LV) 
_PPTS_j 
TMSN' 
N 3 ^ . 0 S i P r 3 
O 
hV 
(LVI) (LVII) (Lviri) 
OSiPrs N3.,^^OSiPr3 
O 
PPTS^ hV 
H 
N ' O, 
+ 
(LIX) (LX) 
0SiPr3 
(LXIII) 
PPTS^ 
TMSN! 
Nsv^^^OSiPrs 
(LXI) (LXII) 
O 
hV 
" X " 
(LXIV) 
H 
N 
X-
(LXV) 
X = CH2/0/S 
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Robert and Alper^' has developed the cobalt mediated carbonylation of 2-vinyl 
azetidines (LXVI) to afford ring expanded seven membered lactams (LXXIl). The 
formation is explained as shown below. 
Co,(CO)8 
NR' 
(LXVi) 
/X Co(C0)4 
-CO 
—N-Co(CO)4 
R 
(LXVII) 
Co(CO)4 
.Co<CO)4 
CO 
Co(CO)4 
(LXX) 
(LXXII) 
Co(CO)4 
-N Co(CO)3 
R' 
(LXVIII) 
Co(CO); 
-N-Co(CO)3 
R' 
(LXIX) 
R' = H/CH2CH:COMe/CH2CH2COOMe/CH2 CH2CN 
The Schmidt reactions on the chloro deri\ative of dimedone (LXXIII) give the 
lactams (LXXIV) and (LXXV) respecti\ely. On the other hand, oxime of 
isophorone (LXXVlll) can be rearranged to the corresponding caprolactams 
(LXXIX) and (LXXX) respectively". These compounds shows central nervous 
system activity 33 
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> \ ^ N O H 
(LXXVIIl) 
(LXXV) 
H2 
H2 
+ 
H O 
(LXXVII) 
O NOH 
(LXXXI) (LXXXII) (LXXXV) 
It is not clear whether the absence of the alternative rearrangement product 
(LXXXV) is due to the ready isomerizations of the (E)-oxime to the (Z)-oxime 
under the reaction condition or to the possibiHty that (LXXXV) does form but 
polymerizes under the reaction conditions. 
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Hj/Pt 
O 
CHAr 
(LXXXVI) Li Me2Cu 
O 
CHjAr 
(LXXXVII) 
O Me 
XH-Ar 
(LXXXIX) 
HNi 
HN3 
ArCHs^ N' .^ H O 
(LXXXVIII) 
Ar-CH M- .^ / H O Me 
(XC) 
Vedejs and Sano^ "* reported the preparation of N-methoxy lactams (XCII) and 
(XCIV), by use of ketones (XCI) and (XCIII) in the Beckmann type rearrangement. 
OMe 
HN(0Me)2 
TMSOTf' 
TMSO. ^N. 
(XCI) 
HN(0Me)2 
TMSOTf 
TMSv^  
^O-Me 
- j><3^0Me 
-»r 
N-OMe 
(XCII) 
O 
OMe 
(XCIII) 
HN(0Me)2 
TMSOTf 
OMe 
(XCIV) 
MeO 
(XCV) 
Roberson and Noerpei''^ have reported the synthesis of p-lactams (XCVII) by the 
use of [3+2] Annulation of Allylsilanes (XCVI) and chlorosulfonyl isocyanate. 
Chlorosulfonyl isocyanate reacted with the a-substituted allylsilane at room 
temperature in toluene to give pyrrolidinone (XCVI), the product on reduction 
provided the stable lactam (XCVII). 
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aso2NCO 
(XCVI) 
Red-Al ® 
R^S 
Me"' N O 
H 
(XCVla) (XCVII) 
Averra et al?^ have reported the synthesis of enantiopure 4-[l-alkylsulfmyl vinyl]-
1,2-dihydronaphthaIenes (XCIX, C, CI and CII) and their Diels-Alder reaction are 
described. Cycloaddition with N-phenyimaleimide occur under thermal condition, 
very slowly but with notable stereoselection, giving in each just one of the two endo 
adducts in high yield. The 16-azasteroids skeleton (XCIX, C, CI and CII) derivative 
undergo chiral auxiliary removal in the presence of iodotrimethylsilane (TMSI). 
NPh NPh 
0-
I (XCIX) 
Rs, R* = isoB. X=H 
Rs, R ' = isoB. X=0\1e 
(C) 
Rs. R* = isoB. X=OMe 
Ss. R ' = isoB, X=OIVIe 
NPM. 
(XCVIII) 
Rs, R ' = isoB, X=H 
Rs, R* = isoB, X=OMe 
Ss. R ' = Bom, X=OMe 
N-Ph N-Ph 
(CI) 
Rs, R* = isoB. X=H 
Rs, R* = isoB. X=OMe 
<;<: R* = RorTi X = n M p 
(CII) 
A selection of azapeptidomimetics containing constraining lactam ring (CIV) have 
been prepared by Mitsunobu cyclization"'^ -^ ^ of serine/homologated serivazaalanine 
derivatives. A novel azaaminoacid acylation method was developed to sterically 
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demanding a-benzyl-serine-azaalaming precursor. The Mitsunobu condition were 
highly efficient in forming the desired azapeptidomimetic lactams (CWf^. 
R,HN 
nH IT 
O 
R4 Ph,P 
R02C-N=N-C02R 
n = l,2or3 
(CIV) 
Cremonesi et al.^^ have reported the synthesis of spiro-P-lactams (CVIII and CIX) 
which were prepared by means of a staudinger ketone-imine reaction starting from 
optically active N-Boc-l,3-thiazolidine-2-carboxylic acid derivatives (CV) and 
imines (CVI). The reaction was stereoselective and afforded spiro-P-lactams (CVIII 
and CIX) with a relative trans-configuration. The absolute configuration of the new 
stereocentres was assigned on the basis of the well-accepted mechanism and 
confirmed by means of X-ray crystals structure analysis. 
COR 
N 
COOH 
(CV) 
COR 
(CVIII) 
+ Ph—CH=N-R, 
(CVI) 
I I-
M e 
Et3N 
CH2CI2 
A 
/ COR 
/ - 0 
-N. 
Ph Ri 
-N 
/ C O R 
C = 0 
(CVII) 
(CIX) 
R = Me/Ph/OtBu 
Ri = CH2Ph / Ph /MeOPh /S02Ph 
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Banik et al!^^ have reported the stereocontroUed synthesis of novel |3-lactams 
(CXII). It is prepared by using polyaromatic imines (CXI) with acid chloride (CX) 
(equivalent) under the staudinger reaction'* .^ The effect of the domestic microwave 
irradiation on this type of reaction has been investigated. The presence of an 
acetoxy group has proven obligatory for their anticancer activity"". 
ZCH,COCI + 
(CX) 
Z = OAc/ OPh 
TEA/Cl^Cl2 
~- 78°C to RT 
(CXI) 
Rachid Touzani and Howard Alper"*^  have reported the synthesis of five, six or 
seven membered ring lactones and lactams by cyclocarboxylation methodology 
using PAMAM dendrimer-palladium complex catalyzed. Palladium complexes 
immobilized onto generation 0-3 PAMAM dendrimers supported on silica in the 
presence of ],4-bis(diphenylphosphino) butane, were used as catalysts for the 
cyclocarboxylation of 2-alllylphenols, (CXIII) affording lactons (CXV) and lactams 
(CXVI) respectively. 
(CXIII) (CXIV) (CXV) (CXVI) 
Carvalho de Souza and Kelly Chibale'''' have given a synthesis of a new series of 
4-aminoquinoline y-and 6-lactams (CXIX) synthesized via Ugi 3-component 
4-centre multicomponent is described by the following reaction. 
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NHCH2(CH2)n-NH2 
(CXVII) 
+ 
R-NC 
(CXVIII) 
CO2H 
MeOH, rt. 12h 
O - TsOH 
3% NH3 /MeOH ci 
NHCH2(CH2)n-N 
(CXIX) 
Troisi et alJ^^ have reported the synthesis of 4-heterosubstituted p-lactams 
(CXXIV). It is prepared by use a palladium-catalyzed [2+2] carbonylative 
cycloaddition of allylbromide (CXXI) with heteroaryliden-anilines (CXX) afforded 
2-azetidinones "N-phenyl substituted (CXXII), with a heteroaryl moiety linked at 
the C4 carbon, and an alkenyl group at C3 carbon. The C3 and the C4 positive could 
be further functionalized inserting alkly and hydroxyl group in the azetidinone ring, 
through the generation of a stable azetidinyl anion then captured by various 
electrophiies. 
N 
Ar 
(CXX) 
.Ph 
H 
CO(400psi), 100°C 
EtjN, Pd (OAc),, PPhj* 
(CXXI) 
Ph. 
Ar 
.0 
N 
? 
LDA 
\ = 
(CXXII) 
N — r 
Ar 
(CXXIII) 
n-BuLl 
E^ 
Ph 
Ar^  
\ — ^ 
O 
(CXXIV) 
Penhoat et al^^ have given a new Mayer's bicyclic lactam (CXXVI) which is 
structurally related to circumdatins/ benzomalvins and asperlicins. An alternative 
procedure making use of the activating agent of carboxylic acid (CXXV) 
(Mukaiyama reagent and FEP) allowed the lactamization process to take place 
under milder condition (CH2 CI2/ 20°C) affording trans-(aS. R, S) (CXXVI) in a fair 
good yield (JO-85%). 
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ROOC 
CHO 
H2N OH 
(CXXV) 
Arumugam et al."'^ have reported a highly regio- and stereoselective synthesis of 
novel spiro pyrrolidines/pyrrolizidines containing P-lactam and oxazolone moieties 
(CXXX) different conditions. 
I H «^%^ 
+ MeNHCHjCOOH 
(CXXVIII) 
OMe 
Reflux Toluene HJ' 
0 / 
-N 
% 
OMe 
(CXXVll) (CXXIX) 
Toluene/CSA( 10 moI%) W°rvv 
MeO 
R Ph 
(CXXX) 
Liu et al.'*^ reported an efficient synthesis of functionalized a-amino caprolactams 
(CXXXni) using ring-closing metathesis (RCM). The key intermediate is a-amino 
a,P-unsaturated caprolatam (CXXXII), and this was obtained from (CXXXI) by 
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RCM of a-amino acrylamide as a key step using Grubbs' second-generation-
catalystB. 
BocHN, 
Mes^ Y ^ Mes 
k I CU
Ru= 
PCyj Ph 
BocHN, BocHN 
Cat. B 
(CXXXI) 
Kayser et al.'^'^ described tlie tiomocliiral 3-hydroxy-4-substituted P-lactams 
(CXXXVII-CXL), wliicli serve as precursors to corresponding a-iiydroxy-P-amino 
acids-key components' of many biological and tiierapeutically important 
compounds. 
(CXXXI V) 
Ha o^Ph 
3 4 
/ "^s 
O PMP (3R,4S) 
(CXXXVII) 
OMe 
(CXXXV) (CXXXVI) HQ, ,,>Ph 
3 4 
-N 
O PMP 
, ent. (CXXXIX) 
HO, 
-Ph 
3 4 
/ ^ • 
O PMP (3S,4S) 
ent. (CXXXVIll) 
HO 
,Ph 
3 4 
O PMP 
(3R.4S) 
(CXL) 
A bicyclic N-substituted P-lactams (CXLIV and CXLV) were prepared by the 
condensation of cyclic alkene (CXLl) with chloro-sulfonyl isocyanates (CXLII) 
gave an intermediate N-chlorosulfonyl P-lactams (CXLIII) in 70% yield. 
Hydrolysis of (CXLlll) gave the resultant products (CXLIV and CXLV) 
respectively.^" 
93 
(CXLI) 
+ 
CISO2NCO 
(CXLIl) 
^ 
O 
(CXLIII) 
/° 
-NH 
(CXLIV) 
(CXLV) 
Koutsourea et al.^^ have given a new synthetic procedure for the preparation of 
steroidal B-D bilactams (CLIV and CLV) respectively. 3P-Hydroxy-7a, 17a-diaza-
B,D-dihomo-5-androsten-7,17-dione (CLV), prepared by using the 3p-acetoxy-5-
androsten-17-one (CXLVI) as starting material and ketalization of the 17-ketone 
and allylic oxidation to the 7-ketone which followed by the Beckmann 
rearrangement at the B and D-steroid ring. 
AcO- AcO 
.0>. ^0 
II. 
(CXLVI) (CXLVII) 
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AcO-
(CLIV) (CLV) 
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Reagent and conditions 
P-TsOH / TEOF / ethylene glycol 90°C one hour. 
i. CrOs / 3,5-DMP / dry dichloromethane, -20C five hours. 
ii. H2NOH. HCl / C5H5N, EtOH, R.T. ten hours. 
V. SOCI2 / THF, CC eight hours. 
V. aqHCl, RT, lh30min. 
vi. H2NOH, HCl / C5H5N, EtOH reflux, two hours, 
vii. SOCI2 / dioxane R.T. five hours, 
viii. LiOH / MeOH IN RT one hour. 
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Discussiom 
After the discovery of the penicillins and the cephalosporin, the past few decades 
have witnessed a remarkable growth in the field of (3-lactams chemistry^^ as this 
heterocycle is a strategic component ol' various antibacterial agent". The need for 
potent and effective P-lactam antibiotic, as well as more effective enzyme 
inhibitors, has motivated synthetic organic chemists to design new functionalized 2-
azetidinones '^'-^^ Application of [3-lactams in medicinal chemistry include their use 
as therapeutic agent for lowering the cholesterol level in plasma"''*^ , as antitumor 
agent" and as enzyme inhibitors (for example inhibitors of cysteine proteases) , the 
substituted hydroxy P-lactams have been the starting materials in the semisynthesis 
of paclitaxel (taxol) and docetaxel (taxotere)^^. Our continuing studies, more 
specifically, spiro-P-lactams are interesting because they can act as antiviral^", 
antibacterial agent''' and also inhibit cholesterol absorption^'. They are also P-lurn 
mimetics", the 4-spiro-P-lactams in particular being synthetic precursor of cyclic 
a,a-disubstituted P-amino acids and peptide derivatives^". Recently, J.D.Hansen et 
al^^ have describe the synthesis of spirolactams (CLVI) that display high binding 
affinity towards CCR4, which is a G-protein coupled receptor that binds, two 
chemokines, macrophage derived chemokine (MDC) and thymus and activation 
regulated chemokins (TARC)^''. CCR4 antagonists as novel agent for treatment of 
asthma and atopic dermatitis^^ To extend our study, in the last years several papers 
have been published on the synthesis of caprolactams which shown to exhibit 
biological as well as physiological activities. In this regards, recently L.A. 
Thompson et c?/.''''reported a variety of substituted amino caprolactams (CLVII) 
inhibitors of the Alzheimers disease-y-secretase. Genetic evidence obtained from 
familials form of AD suggest that increased production of 42 amino acid form of 
AP has a primary role in the disease''^. The Ap peptides are generated by successive 
cleavages of amyloid precursor protein (APP), by P and y-secretase which have 
emerged as strong therapeutic targets for AD intervention'". The most potent hit 
identified was SR 973 (CLVII) and amino caprolactam succinate derivative which 
block Ap formation with {€50= 0.2|j,m. 
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J.C. Pelletier et al^^ have given the preparation of highly substituted y-lactams 
(CXLVI) follicle stimulating hormone receptor agonists. Follicle stimulating 
hormones (FSH) is a 38KDA protein that trigger's maturation of ovarian follicles in 
women and spermatogenesis in men. 
Recently M. Nivasarkar et alP have reported a series of bicyclic N-substituted and 
usubstituted (3-lactams which were synthesized and evaluated as targeted potential 
antimalerial. The compounds M'NR4 (CLIX) and MNRS (CLX) were found to have 
highest potency against Plasmodium falciparum in vitro. Hetero- steroids are 
regarded by synthetic chemists as attractive target molecules because of their 
important bioactlvities and the effect that even minor structural modifications of 
their skeleton can play on their biological role. For instance, the incorporation of a 
nitrogen atom in the steroidal system helps the formation of stable substrate-enzyme 
complexes which are the foundations of antibacterial, antifungal, and many other 
kind of activities shown by azasteroids""^^ These compounds were found to display 
a broad spectrum of biological activities^ '^^ ^ The survey of literature reveals that the 
several papers dealing with the preparation of steroidal lactams have appeared from 
our laboratories* '^^ ' following different procedures. 
/ - \ , 
Ar 
CCR4 receptor antagonists (CLVI) 
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HO' / 
r ^ ^ " ^ r ^ ^ 
O^" 
O 
Follice stimulating hormone; FSH (CLVIl) 
Alzheimer's disease y-secretase (CLVIii) 
-N \ / 
MNR4 
(CLIX) 
-o 
o 
MNR5 
(CLX) 
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Despite the development of a variety of new methods the Schmidt and Beaclcmann 
reaction remain the most convenient and general- methods for steroidal lactams 
synthesis. In this chapter we reported the use of slightly modified version of 
Schmidt reaction as described by Aube et a/.'^'^' where hydrazoic acid has been 
replaced by hydroxy alkyl azide '^ ' ^^ •^ •^^ .^ The purpose of this investigation is to 
extend the scope of these reactions in the preparation of hetero N-hydroxy alkyl 
lactams from easily accessible steroidal a,p-unsaturated ketones such as 
3p-acetoxycholest-5-en"7-one (CLXl) 3p-chlorocholest-5-en-7-on'e (CLXII) 3p-
hydroxycholest-5-en-7-one (CLXIIl) and cholest-4-en-3-one (CLXIV). The ketones 
(CLXI-CLXIV) were 2-hydroxy-2-phenylethylazide and the products obtained were 
characterized on the basis of their spectral and chemical methods. 
CgHiT CRH 8ni7 
(CLXI) AcO 
(CLXII) CI 
(CLXI!) OH 
(CLXIV) 
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Reaction of 3B-acetoxvcholest-5-en-7-one (CLXI) with 2-hYdroxv-2-phenyl-
ethylazide in presence of BFi-etherate:N-2-phenvlethenyi-7a-a2a-B-homo-33-
acetoxvcholest-5-en-7-onc (CLXV) 
3p-Acetoxycholest-5-en-7-one (CLXl:200mg:0.45mmol) was allowed to react with 
2-hydroxy-2-phenylethylazide (250mg:1.54mmol) in dichlorometliane ()5ml) the 
reaction mixture was cooled to 0°C. BF3-etherate (0.5ml) was added dropwise over 
5 minutes immediate gas evaluation was noticed upon addition. The reaction 
mixture was stirred. The progress of the reaction was determined by the TLC. After 
the completion of the workup, evaporation of solvent obtained residual oil which 
crystallized with methanol afforded a solid (CLXV) m.p. 110". 
AcO 
AcO 
CsH, 
N-CH=CH-/~\ 
(CLVI) 
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Characterization of the compound m.p. 110° as N-2-phenvlethenvl-7a-aza B-
honio-3B-acetoxvcholest-5-en-7-onefCLXV) 
The compound m.p. 110° was analysed for C37H53NO3 indicating that the reagent 2-
hydroxy-2-phenylethylazide is incorporated. The I.R. spectrum of the compound 
showed a weak absorption band at 3033, 1626 cm"' could be assigned for the 
aromatic ring. Bands at 1715 and 1248 cm'', were assigned for (OAc,p-oriented) 
and at cm'' 1660 for a,P-unsaturated lactam. Other bands were exhibited at 1605 for 
(C=C) and 1350 cm'' for (C-N). These values supported the presence of lactam 
moiety^ "*. 
On the basis of elemental analysis and I.R. two isomeric structure are possible for 
compound m.p. 110°, The distinction between the two structures (CLXV) and 
(CLXVI) could be made on the basis of its ' H N M R spectral study which showed a 
multiplet at 5 7.46 integrating for the five protons which can be assigned to the 
protons of aromatic ring. Another multiplet ranging 5 6.30-6.39 integrating for two 
protons could be assigned to the protons of N-CH and =CH-Ar. A singlet at 6 5.8 
integrating for one proton indicated the presence of a vinyh'c hydrogen at Q-Has in 
structure (CLXV). A multiplet centered at 6 2.6 integrating for one proton is 
assigned to Cg-pH although one expected it to be at ~6 3.3 but in the alternate 
structure the same proton would not be shifted down beyond 6 2.3 therefore this is 
taken as Cg-pH structure (CLXV) and the slight upfield shift may be due the field 
generated by the aromatic ring. A multiplet was observed, integrating for one proton 
at 53.9 (W!/2=16Hz) which could be attributed to Ca-aH, axial proton (A/B ring 
junction trans)'^ The acetate methyl protons were seen at 62.1 as sharp singlet. The 
angular and side chain methyls were observed at 61.16, 1.14, 1.10 and 0.94. 
In the light of forgoing discussion the compound, m.p. 110°, is tentatively 
characterized as N-2-phenylethenyl-7a-aza-B-homo-3P-acetoxycholest-5-en-7-one 
(CLXV). 
J 02 
Reaction of 3B-chlorocholest-5-en-7-one (CLXII) with 2-hydroxy-2-phenyl-
etlivlazide in presence of iSF^-etherate; N-2-nhenvlethenvl-7a-aza-B-homo-33-
chtorocholest-S-en-7-one(CLXVII) 
The ketone (CLXII) was allowed to react with 2-hydroxy-2-phenyIethyIazide in 
dichloromethane as described earlier. After the completion of the workup, 
evaporation of solvents, residual oil obtained was crystallized from methanol which 
afforded a solid m.p. 103°. ' 
C8H,7 
= C H ^ 
(CLXVII) 
CsHi? 
(CLXVIII) 
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Characterization of the compound solid m.p. 103° as N-2-phenvlethenvl-7a-
aza-B-homo-3B-chlorocholest-5-en-7-one(CLXVn) 
The compound m.p. 103° was analysed for C35H50NOCI indicating that the reagent 
2-hydroxy-2-phenylethylazide is incorporated. The I.R. spectrum of the compound 
showed bands 3024, 1623 could be assigned for aromatic ring, 1665 for 
a,p-unsaturated lactams, 1597 (C=C), 1360 (C-N) and 708 cm'' (C-Cl). These 
values supported the presence of lactam moiety. 
On the basis of the elemental analysis and I.R. two possible isomeric structures 
(CLXVII) and (CLXVIIl) can be written the m.p. 103°. The distinction is based on 
its ' H N M R spectral study. 'HNMR spectrum showed a multiplet at 6 7.40 
integrating for five protons can be assigned to the protons of aromatic ring. Another 
multiplet in the range 56.07-6.16 integrating for two protons could be assigned to 
the proton of N-CH. and =CH-Ar. A singlet at 5 5.6 integrating for one protons 
indicated the presence of a vinylic protons at Cg-H. A multiplet was observed 
integrating for one proton at 53.4 (Wl/2=16Hz) which could be attributed to Cja-H, 
axial proton (A/B ring junction trans). The angular and side chain methyl protons 
were observed at 81.11, 1.02, 0.93, 0.91, 0.87 and 0.71. These values discarded the 
structure (CLXVIIl) in favour of (CLXVII). 
In the light of forgoing discussion and in anology with the previous compound 
(CLXV) the compound m.p. 103" is tentatively characterized as N-2-phenylethenyl-
7a-aza-B-homo-3(3-chlorocholest-5-en-7-one (CLXVII). 
Reaction of 3B-hvdroxycholest-5-en-7-one (CLXIH) with 2-hvdroxv-2-phenvl-
ethvlazide in the presence of BF^-etherate; N-2-phenvlethenvl-7a-aza-B-homo-
3|3-hvdroxvcholest-5-en-7-onefCLXIX) 
The ketone (CLXIIl) was allowed to react with 2-hydroxy-2-phenylethylazide in 
dichloromethane as described earlier. After the completion'of the workup, 
evaporation of solvents, residual oil obtained failed to crystallize. The oil was 
subjected to column chromatography and elution with petroleum ether gave 
N-2-phenylethenyl-7a-aza-B-homo-3p-hydroxycholest-5-en-7one (CLXIX) as a 
pure entity. 
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C8H,7 
N-CH=CHHf ^ 
(CLXll) (CLXIX) 
(CLXX) 
Characterization of the compound oil as N-2-phenvlethenyl-7a-aza-B-homQ-
33-hvdroxvcholest-5-en-7-one (CLXIX) 
The oil (CLXV) was analysed for CjsHsiNOj indicating that the reagent 2-hydroxy-
2-phenylethyIazide is incorporated. The l.R. spectrum of the compound showed 
band at 3)85-3366 cm'' which can be assigned to (-0H), the bands at 3070, 1631 
cm'' could be assigned for aromatic ring, 1662 cm"' for a,P-unsaturated lactam. 
Other bands were exhibited at 1615 (C=C) and 1348 (C-N) cm"'. These values 
supported the presence of lactam moiety. 
On the basis of the elemental analysis and l.R. two possible isomeric structures 
(CLXIX) and (CLXX) can be written the oil. The distinction is based on its ' H N M R 
spectral study. 'HNMR spectrum showed a multiplet at 5 "7.18 integrating for five 
protons can be assigned to the protons of aromatic ring. Another multiplet at 5 6.23-
6.31 integrating for two protons could be assigned to the proton of N-CH and =CH-
Ar. A singlet at 5 5.29 integrating for one proton indicated the presence of a vinylic 
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protons at Ce-H. A multiplet was observed integrating for one proton at 5 4.7 
(W'/2=17Hz) whicii could be attributed to Cs-aH, axial proton (A/B ring junction 
trans). Tiie hydroxy proton was seen at 5 4.1 as singlet. The angular and side chain 
methyl protons were observed at 5 1.0, 0.96, 0.90, 0.84 and 0.72. These values 
discarded the structure (CLXX) in favour of (CLXIX). 
In the light of forgoing discussion the compound as oil is tentatively characterized 
asN-2-phenylethenyl-7a-aza-B-homo-3P-hydroxycholest-5-en-7-one (CLXIX). 
Reaction of cholest-4-en-3-one (CLXIV) with 2-hvdroxv-2-phenvlethvIazide in 
the presence of BFi-etherate; N-2-phenvlethenvI-4-aza-A-homocholest-4a-en-3-
one (CLXXI) 
The ketone (CXLIV) was allowed to react with 2-hydroxy-2-phenylethylazide in 
dichloromethane as described earlier. After the completion of the workup, 
evaporation of the solvents, residual oil obtained failed to crystallize. The oil was 
subjected to column chromatography and elution with petroleum ether gave 
N-2-phenyiethenyl-4-aza-A-homocholest-4a-en-3-one (CLXXI) as a pure entity. 
CgHi? 
CH=CH-N 
(CLXIV) (CLXXI) 
(CLXXH) 
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Characterization of the compound oil as N-2-phenylethenyl-4-aza-A-homo-
cholest-4a-en-3-one (CLXXI) 
The compound (CLXXI) was analysed for C35H49NO indicating that the reagent 2-
hydroxy-2-phenylethylazide is incorporated. The l.R. spectrum of the compound 
showed bands at 3050, 1630 cm"' which could be assigned for aromatic ring. Bands 
at 1658 cm"' is ascribed to a,P-unsaturated lactam. Other bands were exhibited at 
the 1600 (C=C) and 1352 cm"' (C-N). These values supported the presence of 
lactam moiety. 
On the basis of the elemental analysis and l.R. two possible isomeric structures 
(CLXXI) and (CLXXII) can be written the oil. The distinction is based on its 
' H N M R spectral study. ' H N M R spectrum showed a multiplet at 6 6.92-7.35 
integrating for five protons which can be assigned to the protons of aromatic 
moiety. Another multiplet ranging 5 6.07-6.15 integrating for two protons could be 
assigned to the proton of N-CH and =CH-Ar. A singlet at 6 5.5 integrating for one 
proton indicated the presence of a vinylic proton at C4a-H. The angular and side 
chain methyl protons were observed at 6 1.18, 1.11, 1.06, 0.91, 0.87, 0.85, 0.8 and 
0.71. These values discarded the structure (CLXXII) in favour of (CLXXI). 
In the light of forgoing discussion the oil is tentatively characterized as 
N-2-phenyIethenyl-4-aza-A-homocholest-4a-en-3-one (CLXXI). 
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Experimental 
All the melting point are uncorrected. Infrared spectra (I.R) were measured in KBr 
with perkin-Elmer 237 and unichem SP 300 spectrophotometers. The I.R. values are 
given in cm'' (s-strong, m-medium w-weak, br-broad). The ' H N M R spectra were 
run in CDCI3 on various 300Hz instrument with TMS as internal standard. The 
'HNMR value were given in ppm (s-singlet, d-dpublet, t-triplet br-broad 
mc-multiplet centred at). Thin layer chromatography plates were coated with silica 
gel G and developed in an iodine chamber. Light petroleum ethers to fraction 
bp 60-80°. 
3B-Acetoxvcholest-5-ene(CLXXIII) 
A mixture of cholesterol (lOOg) pyridine (150ml) and freshly distilled acetic-
anhydride (100ml) was heated on a water bath for two hours. A light brown solution 
was obtained which after allowing to cool at room temp was poured on to crushed 
ice with stirring. 3p-acetoxycholest-5-ene (CLIII) was obtained as a white 
precipitate which was filtered under suction and washed with water and air dried. 
The crude product was recrystallized from acetone as needles, m.p. 114-115° 
(reported'^ m.p. 116°). 
3B-Chlorocholest-5-ene (CLXXIV) 
Freshly purified thionylchloride (37ml) was added gradually to cholesterol (50g) at 
room temperature. A vigorous reaction ensued with the evolution of gaseous 
product. When the reaction slackened the mixture was gently heated at a 
temperature 50-60° on a water bath for one hour and then poured on to crushed ice 
with stirring. The yellow solid thus obtained was filtered under suction and washed 
several times with ice-cold water and air-dried. Recrystallization from acetone gave 
3p-chlorocholest-5-ene (47 g), m.p. 98-96° (reported^''m.p. 96-97°). 
Cholest-5-ene (CLXXV) 
3p-Chlorocholest-5-ene (lO.Og) was dissolved in warm amylalcohol to the solution 
with the stirring over a period of eight hours. During this period of addition of 
sodium. The reaction mixture was warmed occasionally so as to facilitate the 
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dissolving of sodium metal. When all the sodium metal was dissolved the reaction 
mixture was poured into water. Acidified with hydrochloric acid and allowed to 
stand over night. A white crystalline solid was obtained which was filtered under 
suction and washed thoroughly with water and air dried. The crude product was 
recrystallized from acetone to provided the desired compounds as cubes (7.5g), 
m.p. 94° (reported^^m.p. 95"). 
SB'Hvdroxv 5a, 6S-dibromocholestan (CLXXVIV. 
3p-Hydroxycholest-5-ene (14g) was added in (100ml) of ether to this solution add 
(50ml) of bromine solution with continue stirring. The solution turn yellow and 
prompty set to stiff paste of dibromide. The mixture was cooled to 20''C by stirring 
with a glass rod for 5 minutes to ensure complete crystallization. The product was 
then collected by filtration under suction and washed with cold ether acetic acid 
mixture (3:7) until the filterate completely colourless, m.p. 112° (reported^^ 
m.p. 112°). 
5a. 6B-Dibromocholestan-3-one (CLXXVII) 
SP-Hydroxy 5a, 6p-dibromocholestan (lOg) was suspended in acetone (300 ml-
distilled over KMn04) in a three necked round bottom flask fitted with a stirrer and 
dropping funnel. Jone's reagent (15ml) was then added in small portion from 
dropping funnel in the course of 30 minutes. The temperature of the reaction 
mixture during the oxidation was maintained between 0-5" by external cooling. 
After the addition was completed stirring was continued for 15 minutes and cold 
water (200 ml) was added. The product was filtered under suction and washed 
thoroughly with water, methanol and air dried, m.p. 73° (reported^^ 73-75°). 
Cholest-5-en-3-one (CLXXVIII) 
To a solution of 5a, 6p-dibromocholestan-3-one (5gm) in ether (100ml) and acetic 
acid (2.5 ml) was added zinc dust (7.5gm) in small portion during 30 minutes with 
continuous shaking. After the complete addition, the ethereal solution containing 
suspended zinc dust was filtered in separating funnel. The etherel phase was then 
washed with water dried over anhydrous sodium sulphate (Na2S04). The oily 
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residue obtained, evaporation of tlie solvent was crystallized from methanol to give 
the desired product (3.5g), m.p. 127-120° (reported^^ m.p. 129°). 
Cholest-4-en-3-one (CLVI) 
A solution of cholest-5-en-3-one (5.0gm) in ethanol (50 ml) and oxalic acid (0.6gm) 
heated under reflux for 15 minutes. The reaction mixture was poured into water and 
extracted with ether. Ether extract was washed with water and NaHCOa (5%) and 
again with water. Then dried over anhydrous sodium sulphate CNa2S04). 
Evaporation of the solvent kept only residue which is c.-ystallized from methanol in 
the cold to give ketone (3.2g), m.p. 80° (reported^^m.p. 81-82°). 
3B-Acetoxvcholest-5-en-7-one(CLXI) 
A solution of t-butyl chromate [from t-butyl alcohol (60 ml), CrOa (20 g), acetic 
acid (84 ml) and acetic anhydride (10 ml)] was added at 0°C to a solution of 3p-
acetoxycholest-5-ene (8 g) in carbontetrachloride (150 ml), acetic acid (30ml) and 
acetic anhydride (10 ml). The mixture was heated under reflux for three hour and 
diluted with water. The organic layer washed successively with, water and sodium 
bicarbonate (NaHCOs) solution (5%) and dried over anhydrous sodium sulphate 
(Na2S04). Evaporation of the solvent under reduced pressure furnished an oil which 
was crystallized from methanol to give the desired ketone (4.0 g), m.p. 162° 
(reported^m.p. 162"). 
Reaction of 3B-acetoxvcholest-5-en-7-one (CL? I^) with 2-hvdroxv-2-phenvleth-
ylazide;N-2-Dhenvlethenvl-7a-aza-B-liomo-3B-acetoxvcliolest-5-en-7-one 
(CLXV) 
3P-Acetoxycholest-5-en-7-one (CLXI:200mg:0.45mmdl) was allowed to react with 
2-hydroxy-2-phenylethylazide (250mg:1.54mmol) in dichloromethane (15ml) and 
reaction mixture and was cooled to 0"C. BFs-etherate (0.5 ml) was added dropwise 
over five minutes, immediate gas evaluation was noticed upon addition. The 
reaction mixture stirred for four hours. The progress of the reaction was determined 
by TLC. After the completion of the reaction, oily residue obtained which were 
extracted with ether. The etheral layer washed with water and sodium bicarbonate 
(NaHCOs) solution (5%). Further the organic layer was washed with water and 
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m.p. 
Yield 
I.R. 
HNMR spectrum 
dried over anliydrous sodium sulphate (Na2S04). Evaporation of the solvents, 
residual oil obtained was crystallized from methanol which afforded a solid as N-2-
phenylethenyl-7a-aza-B-homo-3p-acetoxy-cholest-5-en-7-one (CLXV) m.p. 110°. 
N-2-phenvlethenvl-7a-aza-B-homo-3B-acetoxvcholest-5-en-7-one(CLXV) 
110° 
(]82mg:0.35mmol) 
3033, 1626 (aromatic), 1715 and 1248 (OAcp-oriented) 
1660 (a,p-unsaturated lactam), 1605 (C=C) and 
1350 cm-'for (C-N). 
5 7.46 mc(5H aromatic protons), 6 6.30-6.39 mc(2H, N-CH 
and =CI1-Ar), 6 5.8 s(H, Ce-H vinylic proton), 62.6 mcCCg-
pH), 5 3.9 mc(H Cs-aH) and acetate methyl protons at 2.1 
as sharp singlet. The angular and the side chain methyl 
protons were observed at 5 1.16, 1.14, 1.10 and 0.94. 
C 80.39 H, 10.98 N, 6.05 
C 80.41 H, 11.12% N,6.06% 
On the basis of the above evidence the compound can best be formilated as 
N-2-phenylethenyl-7a-aza-B-homo-3p-acetoxycholest-5-en-7-one (GLXV). 
3B-Chlorocholest-5-en-7-one(CLXm 
A solution of t-butylchromate [from t-butyl alcohol (60 ml), CrOs (20 g), acetic acid 
(84 ml) and acetic anhydride (10 ml)] was added at 0°C to a solution (150ml), acetic 
acid (30 ml) and acetic anhydride (10 ml). The mixture was heated under reflux for 
three hour and diluted with water. The organic layer washed successively with 
water and sodium bicarbonate (NaHCOs) solution (5%). Further the organic layer 
was washed with water and dried over anhydrous sodium sulphate (Na2S04). 
Evaporation of the solvent under reduced pressure furnished an oil which was 
crystallized from methanol to give the desired ketone (4.0 g), m.p. 144° (reported^^ 
m.p. 142°). 
Analysis found 
C37H53NO3 requires 
HI 
Reaction of 3P-chlorocholest-5en-7-one (CLXII) with 2-hvdroxy-2-phenvlethyl-
azide in the presence of BF^-etherate; N-2-phenvlethenvl-7a-aza-B-homo-3P-
chlorocholest-5-en-7-one (CLXVin 
3p-Chlorocholest-5-en-7-one (CLXlI:200mg:0.46mmol) was allowed to react with 
2-hydroxy-2-phenylethylazide (300mg:1.85mmol) in dichloromethane (20ml) and 
reaction mixture and was cooled to 0°C. BF3-etherate (0.5 ml) was added dropwise 
over 5 minutes, immediate gas evaluation was noticed upon addition. The reaction 
mixture stirred for four hours. After the completion of the usually workup, 
evaporation of the solvents obtained residual oil which crystallized with methanol 
afforded a solid as N-2-phenylethenyl-7a-aza-B-homo-3p-chlorocholest-5-en-7-one, 
m.p. 103°. 
N-2-phenylethenyl-7a-aza-B-homo-3B-chlorocholest-5-en-7-one(CLXVII) 
Bellestain Test 
m.p. 
Yield 
I.R. 
'HNMRCDCI3 
positive 
103° 
(142mg:0.37mmol) 
3024, 1623 (aromatic), 1665 (a,P-unsaturated lactam), 
1597 (OC), 1360 (C-N) and 708 cm"' (C-Cl). 
6 7.40 mc(5H, aromatic protons), 6 6.07-6.16 mc(2H, N-
CH and =CH-Ar), 5 5.6 s(H, Ce-H vinylic proton), 62.3 
mc(H, Cg-pH) and 5 3.4 mc(H, Cj-aH). The angular and 
the side chain methyl protons were observed at 61.11, 1.02, 
0.93, 0.91, 0.87 and 0.71. 
C 80:94 H, 10.79 N, 6.09 
C35H50NOCI requires: C 80:99 H, 10.81 % N, 6.11 % 
On the basis of the above evidence the compound can best be formilated as N-2-
phenylethenyl-7a-aza-B-homo-3p-chlorocholest-5-en-7-one(CLXVll). 
Analysis found 
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3B-Hvdroxvcholest-5en-7-oiie(CLXIII) 
3P-Hydroxycholest-5en-7-one (500mg) was taken in ethanol (10 ml) and cone, 
hydrochloric acid (1.5ml) was added mixed together.' The reaction mixture was 
refluxed for two hours. After the completion of the reaction crystals separated by 
filtration, washed thoroughly with water. Recrystallized with methanol gave 
3P-hydroxycholest-5en-7-one as solid (400 mg)as a solid m.p. 106-108°. 
Reaction of 3B-hvdroxycholest-5-en-7-one (CXLIX) with 2-hvdroxv-2-phenvl-
ethvlazide in presence of BF^-etherate; N-2-phenvlethenvl-7a-aza-B-homo-33-
hvdroxycholest-5-en-7-one (CLXIX) 
3(3-Hydroxycholest-5-en-7-one (CLXVIll:250mg:0.62mrnol) was allowed to react 
with 2-hydroxy-2-phenylethylazide (325mg:2.0mmol) in dichloromethane (20 ml) 
and reaction mixture and was cooled to 0°C. BFs-etherate (0.5 ml) was added 
dropwise over 5 minutes, immediate gas evaluation was noticed upon addition. The 
reaction mixture stirred for four hours. The progress of the reaction was determined 
by the TLC. After the completion of the reaction, the reaction mixtures was 
extracted with ether. The ether layer washed with water and sodium bicarbonate 
(NaHCOs) solution (5%). Further the organic layer was washed with water and 
dried over anhydrous sodium sulphate CNa2S04). Evaporation of the solvents 
afforded as an oil which failed to crystallize. The oil was subjected to column 
chromatography and elution with petroleum ether gave N-2-phenylethcnyl-7a-aza-
B-homo-3P-hydroxycholest-5-en-7-one (CLXIX) as a pure entity. 
N-2phenvlethvlenvl-7a-aza-B-honio-3(3-hvdroxvcholest-5-en-7-one (CLXIX); 
Elution 
Yield 
I.R. 
Petroleum ether 
(200mg : 0.38 mmol) 
3185-3366 (-0H), 3070, 1631 (aromatic), 1662 
(a,p-unsaturated lactam), 1615 (C=C) and 1348 cm'' (C-N). 
HNMR(CDCl3) : 5 7.18 mc(5H, aromatic protons), 5 6.23-6.31 mc(2H, N-
CH and =CH-Ar), 6 5.29 (H, Cg-H vinylic protons), 63.7 
mc(H, CyaH} and 5 4.2 broad band (OH). The angular and 
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side chain methyl protons were observed lit 1,0, 0.96, 0,90, 
0.84 and 0.72. 
Analysis found : C,81:12 H, 11.01 N,6.17 
CjsHsiNOz requires : C, 81:19 H, 11.13 N, 6.18% 
On the basis of the above evidence the compound can best be formilated as N-2-
phenylethenyl-7a-aza-B-homo-3p-hydroxycho!est-5-en-7-one (CLXIX). 
Reaction of cholest-4-en-3-one (CD with 2-hvdroxv-2-phenvlethvlazide in 
presence of BFi-etlierate; N-2-nlienvlethenvl-4-aza-A-homo-cholcst-4a-en-3-
one (CLXXI) 
Cholest-4-en-3-one (CLXIV:200mg:0.52mmol) was allowed to react with 
2-hydroxy-2-phenylethylazide (285mg;1.75mmol) in dichloromethane (20ml) and 
reaction mixture and was cooled to 0°C. BFs-etherate (0.5 ml) was added dropwise 
over 5 minutes, immediate gas evaluation was noticed upon addition. The reaction 
mixture stirred for five hours. After the completion of the reaction, oily residue 
obtained which were extracted with ether. The etheral layer washed with water and 
sodi um bicarbonate (NaHCOj) solution (5%). Further the organic layer was washed 
with water and dried over anhydrous sodium sulphate (Na2S04). Evaporation of the 
solvents residual oil obtained failed to crystallize. The oil was subjected to column 
chromatography and elution with petroleum ether gave N-2-phenylethenyl-4-aza-A-
homo-cholest-4a-en-3-one (CLXXI) as a pure entity. 
N-2-phenvlethenvl-4-aza-A-homo-cholest-4a-en-3-one (CLXXI) 
Elution : Petroleum ether 
Yield : (78mg -.0.34 mmol) 
1-R- : 3050, 1630 (aromatic), 1658 (a,p-unsaturated lactam), 
1600 (C=C) and 1352 cm"' (C-N) 
' H N M R (CDCI3) : 56.92-7.35 mc(5H, aromatic protons), 6 6.07-6.15 (2H, N-
CH and =CH-Ar), 6 5.5 (H, C4a-H vinylic protons). The 
angular and side chain methyl protons were observed at 
1.18, 1.11, 1.06, 0.91, 0.87, 0.85, 0.8 and 0.71. 
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Analysis found : C,8I:12 H, 11.01 N,6.21 
C35H49NO requires : C, 81:19 H, 11.13 N, 6.23% 
On the basis of the above evidence the compound can best be formilated as N-2-
phenylethenyl-4-aza-A-homo-cholest-4a-en-3-one(CLXXI). 
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Chapter Four 
Mass spectral studies of Thiazoles 
Discussion 
A survey of literature revealed that no systematic mass spectral study of steroidal 
thiazoles has been reported and many such compounds being synthesized recently'. 
In the previous chapter we have described the combined with the fact that our 
laboratories has reported the mass spectral studies of several class of steroidal 
compounds in the recent past^ •^ prompted us to examine the mass spectra of some 
steroidal thiazoles as an attempt to establish spectra structure relationship. The 
compounds included in the study are 2'-N-phenylamino-5a-cholest-6-eno[6,7-d] 
thiazole (I) 3P-acetoxy-2'-N-phenylamino-5a-cholest-6-eno[6,7-d] thiazole (II), 
3p-proponoxy-2'-'N-phenlyamino-5a-cholest-6-eno[6,7-d] thiazole (III), 2'-amino-
5a-cholest-6-eno[6,7-d] thiazole (IV), 3p-acetoxy-2'-amino-5a-choIest-6-eno[6,7-
d] thiazole (V) and 3p-proponoxy-2'-amino-5a-cholest-6-eno[6,7-d] thiazole (VI). 
These compounds are structurally very close to each other, it was anticipated that 
they will follow similar fragmentation patterns thus offering a simple and effective 
method of their characterization by mass spectrometry. It is indeed observed that 
they show close resemblances and hence can be used for characterisation of such 
compounds. 
The suggested fragmentation pathways get support from the composition of the 
important ions. In the absence of mass spectra of appropriate deuterated analogues 
the suggested mechanism of fragmentations remains tentative, though substitutes in 
some cases compensate this deficiency to some extent. 
In this Chapter, Ihc mass spcclrum of 2'-N-phcnylan>in()-5(x-ch()lcsl-6-ciK) |6,7-d| 
thiazole (I) ha.*) been discussed in detail and Ihis may be considered as Ihc 
representative of model for other compounds (II and 111)'"^ . 
CsHiy 
AcO 
NH-Ph NH-Ph 
(1) (H) 
122 
PrO 
AcO 
CgHn CsH, 
(HI) 
NH-Ph 
CgHiv 
NH2 
(V) 
Pro 
(IV) 
CsH 8ni7 
The mass spectrum of 2'-N-phenylamino-5a-choIest-6-eno[6,7-d] thiazole (I) 
(Fig.l) gave a prominent molecular ion at m/z 518 (C34H50N2S). Other significant 
ion peaks were observed at m/z 517 (M-H), 503 (M-CH3), 462 (M-C4H8), 441 (M-
Ph), 426 (M-CgHgN), 411 (426-CH3), 405 (M-C8H,7), 400 (M-118), 387 (M-140), 
349 (462-C8H,7), 301 (441-C8H,7 CH=CH2), 296 (M-222), 281(296-CH3), 311 
(M-207), 309 (M-209), 240 (C14H12N2S), (122, C7H7S) and lower mass. 
The formations of the more interesting and important fragments have been 
suggested in the following schemes. 
m/z 517 (M-H) 
The ion m/z 517 obviously arises by the loss of one hydrogen from molecular ion. 
The loss of hydrogen may involve one hydrogen form C5 or CR position or from 
NHPh as shown in Scheme-I. As pointed out earlier this suggestion does not have 
the support of mass spectrum of appropriate deuterated analogues. 
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m/z 503 (M-CH3) 
The loss of methyl group form the molecular ion can occur in several ways, the 
most preferred loss is likely to involve C13 or Cjo-methyl (Scheme-!). 
m/z 462/461 
This ion most probably arises by the loss of a ring A from molecular ion as shown 
(Scheme-I). 
SCHEME-I 
N 
m/7. 503 
m/V 461 
m/:i517 
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nvz 503 
m/z 441 (M-Ph) 
The formation of the ion m/z 441 can be shown to arise.by the loss of phenyl group 
from the molecular ion m/z 578. 
r8" i7 
H-N-Ph 
(I) 
LX) 
h^M 
-±f) 
N 
H-N-Ph 
ni/z441(C28H«N2S) 
ni/z426(M-NHPh)/411 
The ion peak 426 corresponds to the loss of -NH-Ph (mass unit 92) form the 
molecular ion m/z 518. 
8"17 
(I) 
-CH3 
m/z 503 (C33H47N2S) 
-NHPH 
-NHPH 
m/z 426 (C28H44NS) 
-CH-, 
m/z 411 (C27H4,NS) 
m/z 405 (M-CgHn side chain) 
The loss of the side chain (CsHy) is of regular occurrence in the mass spectra of 
steroidal compounds belonging to the cholestane series. 
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CgHiT 
EB 
NH-Ph Nl l -Ph 
NH-lMi 
CxH unn 
NH-Ph 
NH-PK 
nVz405 (C2bH33N2S) 
m/z400(M-118) 
The ion m/z 400 corresponds to the loss PhNHC=N (mass unit 118) from the 
molecular ion. 
r-St-'lV 
NH-Ph 
-N=C-NH-PH r " ' ^ 
NH-Ph 
m/z 400 (C27H44S) 
m/z 378 (M-C8H,7CH=CH2) 
The ion m/z 378 corresponds to the loss of mass unit 140 from the molecular ion. 
The mass unit is built up of the side chain and a part of ring D, this loss is of 
common occurrence in the mass spectra of the cholestane derivatives. 
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CsHiT CsHiT 
CsHi7 
N H - P h N H - P h 
N H - P h 
-C8ll|7CH=CH2 
>• 
N = { N l l - P h 
N H - P h 
nV/.378(C24H,„N2S) 
m/z 364/363 
The ions are derived from combined of the side chain and ring D (C15, C16 and C17) 
as shown below. 
NHPh NHPh 
-H' 
NHPh 
m/z 364 (C23H28N2S) 
m/z 364 (C23H2gN2S)-
NHPh 
m/z 363 (C23H27N2S) 
m/z 349 (C22H25N2S) 
This can be shown to arise by the loss of side chain from the ion m/z 462. 
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^'yti^u 
NHPh NHPh 
m/z 349 (C22H25N2S) 
NHPh 
m/z462(C3oH42N2S) 
m/z 301 (441-C,„H2o) 
This ion peak at m/z 301 is nearly as strong as the base peak. Most probably the loss 
involve the expulsion of C8H,7-C=CH2 from the 441. 
CxH 8»17 CsH 8"I7 CsH S"17 
m/z 441 
m/z 301 (CiiiHjsN^S) 
m/z 296 (C18H20N2S) and m/z 281 (CnHnNzS) 
The m/z 296 ion may arise by the loss of ring C and D along with the side chain 
from the molecular ions. Further loss of methyl group from the ion m/z 296 gives 
the ion m/z 281. 
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QsHp 
NH-Ph NH-Ph 
(I) 
NH-Ph 
m/z296(C,8H2oN2S) 
r^j. 
^ X l . 3 . . - . 
^ - ^ • ) ^ ' ' 
CXA 
N=<, 
NH-Ph NH-Ph 
m/z281 (C17H17N2S) 
NH-Ph NH-Ph NH-Ph 
-CH, 
NH-Ph NH-Ph 
m//.2%(C,„H2|,N-,S) 
NH-Ph 
m//.281 (rpHivNiS) 
in/z240(CuH,2N2S) 
The genesis of the ion m/z 240 can be shown according to the following sciieme. 
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NHPh 
m/2 462(C3oH42N2S) 
NHPh' NHPli 
m/z240(C,4H|2N2S) 
tn/z 231 (CisHigS) 
This ion may be shown to arise by the following scheme. 
NHPh 
m/z 349 (C22H25N2S) m/z 231 (C,5H,9S) 
m/z 123 (C7H7S) 
The ion m/z 123 may be shown to arise from the ion 240 as follows. 
H-N-Ph 
m/z240(C|4H|2N2S) 
"N-Ph 
N^C-N-Ph 
N-Ph 
m/z 123(C7H7S) 
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The mass spectra of 3(3-acetoxy-2'-N-phenylamino-5a-cholest-6-eno[6,7-d] thiazole 
(II) (Fig II), 3P-proponoxy-2'-N-pheny[amino-5a-choIest-6-eno [6,7-d] thiazole 
(III) (Fig.III) were comparable with 2'-N-phenyl amino-5a-cholest-6-eno [6,7-d] 
thiazole (I) fig (1) 
The mass spectrum of 3p-acetoxy-2'-N-phenylamino-5a-cholest-6-eno [6,7-d] 
thiazole (II) FigXIO^ was quite similar to that of the (I). 
The molecular ion peak of (II) was observed m/z 576 (C36H52N2SO3). Most of the 
fragment ions observed in the spectrum of (II) corresponded to the ions obtained 
and discussed in the spectrum of (I) with a difference of two. mass unit, after the 
elimination of CH3COOH. Some of these ions were m/z 575 (M-H), 561 (M-CH3), 
516 (M-CH3COOH), 499 (M-77), 484 (M-NH-Ph), 463 (M-CsHiy), 462 (516-54), 
439 (516-77), 436 (M-C8H|7-CH=CH2), 424 (516-NHPh), 403 (516-C8H|v). 398 
(516-118), 376 (5I6-C10H20), 362 (516-154), 359 (499-140), 349 (462-113), 299 
(439-140), 294 (CsHi^NzS), 279 (C.vH.sNjS), 240 (CMHIZNJS), 231 iC,,H,,S), 
123 (C7H7S) and lower mass peaks. 
The mass spectrum of 3(3- proponoxy -2'-N-phenyiamino-5a-cholest-6-eno [6,7-d] 
thiazole (III) Fig (III), was comparable with that of (1). The molecular ion peak was 
observed at m/z 589 (590-H), 575 (M-CH3), 516 (M-CH3COOH), 513 (M-77), 
498 (M-NH-Ph), 477 (M-CgHiy), 462 (516-54), 450 (M-140), 439 (516-77), 424 
(516-NHPh), 403 (516-C8H,7), 398 (516-118), 376 (516-C8H,7CH=CH2), 373 
(513-140), 362 (516-C8H,7-CH2-CH-CH2), 349 (462-C8H,7), 299 (439-140), 294 
(C8H18N2S), 279 (C,7H|5N2S), 240 (C14H12N2S), 231 (C.sHigS), 123 (C7H7S) and 
lower mass peaks. 
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SCHEME - II 
nVz561 
(C35H49N2SO2) * -CH3 
(C28H35N2SO2) -« 0 
/ A-y^ . C H 3 - C - O 
(C26H32N2SO2) -* 
N H - P h 
(M". 576; C36H52N2SO2) 
-CH3COOH 
-H* 
-NHPh 
• nVz575(C36H5oN2S02) 
.nVz484(C3oI-Li5N2S02) 
-f-h 
-*. m'z499 (C30H47N2SO2) 
-C8H,7CH=CH2 
nVz359(C2oH27N2S02) 
nyz462 
(C30H42N2S) ^ 
-CgHn 
nyz349 
{C22H25N2S) 
nVz439 
(C28H43N2S) < -
CgHn 
-C4H6 
-Ph 
-140 
nyz299 
(C,8H23N2S) 
-C10H20 
.nVz376(C26H32SN) 
-PhNHC=N 
N H - P h 
(nVz516;C34H48N2S) 
113 
I (C8H,7) 
nVz403 (C26H31N2S) 
*.m'z398(C27H42S) 
-222 
^nVz294(C|8H,8N2S) 
- C H J 
nyz279(C,5H,5N2S) 
"^^'^'^fc. nVz424 (C28H12NS) 
ll54_^m'z362(C23H26N2S) 
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SCHEME - III 
m/z 450 ^-'^ioH20 
(C27H34N2SO4) 
O 
CH3—CH2-C—O 
nVz513 -Pl i 
(C31H49N2SO2) " NH—Ph 
(Mt590;C37H54N2SO2) 
-C2H5COOH 
-CgHp 
*.m/z477(C29H37N2S02) 
-CH3 
-NHPh 
*-m/z575(C36H5|N2S02) 
*.nVz498(C3|H48NS02) 
- H ' 
->• m/z 589 (C37H53N2SO2) 
m/z 462 
(C30H42N2S) 
-CgH, 
111//. 349 
(C22H25N2S) 
iWz4S0 
(C27H34N2SO4) 
-140 
m/z 450 
(C,8H23N2S) 
-C4H6 
-f-h 
Nll-Ph 
(m/z516;C34H48N2S) 
-IsIHPh 
nVz424(C28ll42NS) 
-C10H20 
-<^8H,7 ^ 
• m/z376(C26H32S) 
• m/z403(C26H3,N2S) 
154 
-118 
-»-ni//3f)2(Ciilb(,N,S 
nVz398(C27ll42S) 
-222 
-^m/z294(C,sH|8N2S) 
-CH3 
m/z279(C|5H|5N2S) 
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The mass spectrum of 2'-amino-5a-choIest-6-eno [6,7-d] thiazole (IV) has been 
discussed in details and this may be considered as the representative of model for 
other compounds (V and VI) (fig. IV) gave a molecular ion peak at m/z 442 
(C28H46N2S). Other significant ion peaks are at m/z (M-CH3), 400 (M-CH2N2), 386 
(M-C4H8), 329 (M-C8H17), 302 (M-C,oH2o), 301 (302^H), 273 (C16H21N2S), 246 
(C|4H,8N2S), 231 (CsHioS), 221 (C,2H|7N2S), 216 (CuHi^S), 164 (C8H8N2S), 123 
(164-41) and lower mass peak. The fragmentation leading to the formation of 
interesting and important sons have been suggested in the following scheme. 
m/z 427 (M-CH3) 
This ion obviously results by the loss of a methyl group from the molecular ion. 
Loss of methyl group(s) from steroids is of common occurrence/ most preferred 
loss is likely to involve C13-CH3. 
r8H|7 <r8H|7 
M.M42 m/z 427 
m/z 400 
This ion peak at m/z 400 though a weak one but could be of significant in the 
characterization of the thiazole moiety. The ion corresponds to the loss of 
—N=C—NH2 from the molecular ion. 
gn,7 
m/z 400 (C27H44S) 
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m/z 386 (M-56)/385 
The ion peak at m/z 386 is nearly as strong as tlie base peak. Tlie formation of this 
fragment ion can be explained by loss of ring A as shown below. 
NH2 
(m/z385(C24H37N2S) 
NH2 
m/z386(C24H38N2S) 
m/z 329 (M-113; side chain) 
The ion peak at 329 corresponds to the loss of CgHi? (mass unit 113) from the 
molecular ion. The loss of side chain is of regular occurrence in the mass spectra of 
steroidal compound. It can also be shown according to the following. 
8H|7 
-QHiv^ 
(I) 
NH2 
m/z 329 (C20H29N2S) 
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m/z 302 and 301 
The ion m/z 302 corresponds to the loss of mass unit 140 from molecular ion. The 
mass unit 140 built up of the side chain and a part of ring D (Ci6 and C17) 
CsHn 
0^ 
N=-< 
CgHn 
rS ! 1 ^^ 
^ \ J 
l U . 
p8H|7 
r 1 •^^  
"1 
\ + / \ 
NH2 
NH, 
(I) 
NH2 
m/z302(C,8H26N2S) m/z 301 (CgHjiiN.S) 
273 (386-C8H,7) 
The ion peak at 273 corresponds to the loss of the CgHi? side chain (mass unit 113) 
from the ion m/z 386. 
-CsHu^ 
m/z 273 (C16H21N2S) 
NII2 
(m/z 3 86) 
246 (386-C,oH2o) 
The loss of side chain and piart of ring D gave an important ion peak at m/z 246. 
These losses important ion peak at m/z 246. These loses may occur from the 
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molecular ion itself or from some daughter ions. The formation of these ions, 
corresponding to the combined loses of the side chain and part of ring D has been 
shown to occur in the manner shown below: 
8H|7 
:> 
N==^ 
NH, 
c 
N 
NH, 
^JH2 
NH2 
• < *• 
H, 
NH2 
m/2 246(Ci4H|gN2S) 
m/z 231 (CjsHigS) 
This ion can be shown to a rise from the ion m/z 273 by the loss of ' ^ ^ ^ " ' ^ " 2 
N = C - N H ^
 
m/z 273 m/z 231 (CijHigS) 
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m/z 164 (CgHgNzS), 163 (CgHvNzS) 
These can be shown to be formed from the base peak 386. 
-gHp CgHi7 
H 
I 
• ^ ' 
\ 
NH, NH, 
H 
- v ^ ^ 
-H ' 
N 
NH2 NH2 
m/zl64(C8H8N2S) m/z 163(QH7N2S) 
m/z 123 (C7H7S) 
This important ion may be shown to arise from the ion m/z 164 by the loss of 
N = C - N H 2 
m/z 164 
N=i=C 
H-N-H 
^ > 
NH 
m/zl23(C7H7S; 
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The mass spectra of 3P-acetoxy-2'-amino-5a-cholest-6-eno [6,7-d] thazole (V), 3P-
proponoxy-2'-amino-5a-cholest-6-eno [6,7-d] thazole (VI) were comparable with 
that of 2'-amino-5a-cholest-6-eno [6,7-d] thazole (IV). 
The mass spectrum of (IV) (flg.lV) gave molecular ion peak at m/z 500. Most of the 
fragment ions were formed after the loss of CH3COOH as 1,2-elemination process. 
The ions m/z 440, 425, 398, 386, 385, 327, 300, 291, 273, 246, 231, 164, 163, 149 
and 123 obtained from (IV) are comparable with those obtained from (V) with 2 
mss unit difference. Acetate containing ions m/z 485, 387, 360 and 359 were also 
recorded in the spectrum of ( V), which can also be accounted by fragmentations 
shown in case of (IV), formation of various fragment ions from (II) in shown in 
scheme (IIZ). 
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SCHEME - IV 
C8H,7 
-C8H,7CH=CH2 
nVz360(C2oH28N2S02) 
- H 
m/z359(C2oH27N2S02) 
-CgHj-i 
-(^H3 
nVz387(C>2H3|N2S02) 
m/z485(C29H45N2S02) 
(Mt 500; C3oH4gN2S02) 
-CH3COOH 
CgH|7 
nVz425 
(C27H41N2S) 
-CHoN-, 
nVz373 
(C26H39S) 
nVz425 
(CMH,gN2S) 
-dxH 8"17 m/z327(C2oH27N2S) 
-dH2CH2C8Hi7 nVz300(CigH24N2S) 
-CH2N2 ^
 m/z398 (C27H42S) 
-140 nVz386(C-,4H3gN-,S)^ J l i l l ^ m/z273 
(C16H21N2S) 
nVzl23 
(C7H7S) 
- N = C - N H "^z425 
' {C8H8N2S) 
-CH-) 
nVzl49 
(C7HSN2S) 
- N = C - N H - , 
m/z273 (pjJj 
(C15H19S) 
- C H . 
m/z261 
(C14H16S) 
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The mass spectrum of 3(3-proponoxy-2'-amino-5a-cholest-6-eno [6,7-d] thiazole 
(VI) (Fig.VI) was quite similar to that of (IV). The highest mass peak was observed 
at m/z 514, This is also the base peak of the molecule (VI). The other fragment ions 
were obtained at m/z 499, 473, 440, 401, 398, 386, 385, 374, 373, 327, 300, 291, 
273, 246, 231, 164, 163, 149, 123 and lower mass peaks. It evident from ions that 
most of them arise after the loss of a molecule of propionic acid from the molecular 
ion and a difference of two mass unit is therefore observed in the fragment ions 
obtained from (VI) and those from the 3(S-substituted thiazole (VI) Scheme (V) 
shows various fragment ion from (IV-VI). A comparison of the spectra of these 
three thiazoles (IV-VI) (Fig. IV-VI) clearly showed remarkable similarity between 
them which can be made use of in the interpretation of the of oth,er such 
compounds. 
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SCHEME -V 
O 
II 
CH3CH2C-O 
-C8Hi7CH=Cl42 
m/z374 (C21H30N2SO2) 
nVz373(C2|H29N2S02) 
m/z499{C3oH47N2S02) 
^ nVz401 (C23H33N2SO2) 
(M^.574;C3iHsoN2S) 
m/zl64 
(C8H8N2S) -222 
- N = C - N H 
m/zl23 
(C7H7S) 
-C!H3 
m/zl49 
(C7H5N2S) 
-CH3CH2COOH 
CsHiv 
-CgHn 
nVz327(C2oH27N2S) 
-_C2oH20^ m/z300 (C,8H24N2S) 
NH2 
(M'".440;C28H44N2SO) 
-C;4H6 
nVz386(C24H3gN2S) 
-C?8Hl7 
nVz273(Ci6H2,N2S) 
-140 ^ m/z246 
(C14H18N2S) 
- N = C - N H , m/z23l 
(C15H19S) 
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The mass spectrum were measured on JMS-300/A1E MS-9, mass spectrometer at 70 
ev using direct insertion sample inlet system at a source temperature of about 
200°C. The accurate mass measurements were related to fragment ions of 
heptacosafluorotributylamine at a resolving power of 15,000. 
The values of m/z of fragment ion from various compounds are tabulated below. 
The values in parenthesis are relative abundance (%) of the peak with respect to 
base peak taken as 100%, and the compositions of fragment ions as determined by 
accurate mass measurement. 
2'-N-phenvlamino-5a-cholest-6-eno f6,7-dl thiazole (I) 
M^ 518 (100.00; C34H50N2SO2), 517 (33.00; C3,,H49N2S),504 (1.90), 503 (4.00; 
C33H47N2S), 464 (3.50), 463 (24.3), 462 (61.00; C30H42N2S), 461 (12.50; 
C30H41N2S), 442 (13.50), 441 (40.00; C.sHisN.S), 428 (5.46), 427 (5.20), 426 
(23.50; C28H44NS) 425 (2.00), 411 (3.00; C27H4,NS), 410 (2.80), 405 (5.20; 
C26H33N2S), 400 (3.50; C27H44S), 392 (1.53), 391 (1.60),-378 (13.50; C24H30N2S), 
377 (5.00), 365 (2.00), 364 (6.70; C23H28N2S), 363 (5.08; C23H27N2S), 362 (2.50), 
349 (10.00; C22H25N2S), 248 (5.60), 347 (6.20), 332 (1.50), 302 (4.03), 301 (34.00; 
CisHssNjS), 300 (2.07), 296 (4.20; CigHzoNsS), 282 (2.00), 281 (9.09; C,7H,7N2S), 
280 (2.70), 272 (2.00), 271 (3.50), 249 (1.60), 248 (2.30), 241 (5.00), 240 (24.00; 
C14H12N2S), 239 (1.80), 232 (3.50), 231 (13.40; C|5H,9S), 216 (2.50), 215 (l.OO)i 
205 (1.50), 204 (2.40), 202 (1.50), 201 (6.03), 199 (13.00), 195 (3.80), 194 (9.06), 
181 (2.50), 179(3.7), 177(2.50), 176(7.00), 175(11.5), 166.(2.40), 165(8.00), 164 
(20.00), 163 (2.91), 153 (10.25), 150 (4.37), 149 (22.30), 147 (1.50), 146 (6.00), 
145 (11.28), 137 (1.50), 136 (1.60), 126 (5.05), 124 (13.10), 123 (28.21; C7H7S), 
122 (12.00), 119 (11.00), 118 (3.17), 107 (26.00), 105 (23.42), 94 (1.50), 93 (2.18), 
92 (32.50), 91 (8.00), 83 (11.07), 81 (50.00), 78 (-10.00), 77 (68.00), 69 (11.00), 67 
(18.00), 57 (6.00), 56 (18.00), 55 (40.00), 54 (46.00), 53 (5.00), 44 (1.45), 43 
(86.00), 41 (46.58). 
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3B-Acetoxv-2' -N-phenvlamino-5a-cholest-6-eno [6,7 -d1 thiazole (II) 
M+ 576 (100.00; C36H52N2SO2), 575 (36.50; CafiHsiNzSOn), 562 (2.50), 561 (4.46; 
C35H46N2SO2), 518 (11.20), 517 (16.08), 516 (20.13; C34H48N2S), 515 (12.50), 499 
(13.60; C30H47N2SO2), 498 (11.50), 484 (3.52; C30H46NSO:), 483 (2.70), 482 (2.18), 
464 (2.20), 463 (5.30; C28H35N2SO2), 462 (3.50; C30H42N2S), 440 (1.50), 439 (3.15; 
C28H43N2S), 438 (2.30), 436 (3.80; C26H32N2SO2), 425 (2.00), 424 (3.50), 404 
(3.40), 403 (11.30; C26H31N2S), 398 (3.00; C27H42S), 397 (2.40), 396 (2.50), 376 
(12.50; C20H27N2SO2), 358 (10.00),350 (2.00), 349,(5.00; C22H25N2S), 348 (3.50), 
300 (10.00), 299 (5.00; C18H23N2S), 295 (1.50), 294 (4.00; CigHigNjS), 280 (2.80), 
279 (6.00; CnHisNzS), 270 (2.00), 269 (2.00), 268 (2.50), 249 (1.50), 248 (1.50), 
242 (2.10), 240 (4.50; C,4H,2N2S), 231 (2.50; CisHigS), 230 (2.43), 229 (6.30), 228 
(3.30), 225 (3.50), 216 (1.00), 213 (2.64), 204 (3.50), 203 (2.50), 201 (2.57), 199 
(9.56), 198 (1.50), 197 (4.05), 180 (2.08), 179 (5.00), 178 (10.50J, 177 (2.90), 165 
(1.50), 164 (5.30), 163 (10.28), 149 (7.14), 148 (7.50), 146 (1.50), 145 (17.50), 126 
(3.00), 124 (5.00), 123 (13.40; C7H7S), 122 (6.50), 119 (4:20), 118 (3.53), 107 
(3.00), 105 (5.70), 103 (15.40), 95 (2.80), 94 (3.90), 92 (14.20), 88 (2.48), 87 
(25.20), 8 (5.00), 81 (24.00), 78 (8.30), 77 (31.00), 76 (7.00), 66 (2.35), 65 (1.50), 
64 (8.40), 57 (25.35), 56 (12.20), 55 (16.00), 44 (5.50), 43 (47.88),41 (30.90). 
3B-Propionoxv-2'-N-phenvlamino-5a-cholest-6-eno [6,7-d] thiazole (III) 
M* 590 (100.00; C37H54N2SO2), 589 (34.00; C37H53N2SO2), 575 (6.70; 
C36H5,N2S02), 574 (3.40), 517 (1.52), 516 (4.50; C34H48N2S), 514 (2.32), 513 
(6.56; C3,H49S02), 498 (2.62), 479 (2.08), 478 (2.52), 477 (3.50; C29H37N2SO2), 
462 (5.15; C30H42N2), 461 (2.9), 450 (2.49; C27H34N2SO2), 449 (3.48), 439 (2.40), 
426 (3.50), 424 (1.39; C28H42NS), 404 (3.17), 403 (5.37; C26H3,N2S), 398 (3.10), 
397 (1.50), 396 (1.50), 376 (3.36; C26H32S), 373 (18.20; C21H29N2SO2), 364 (2.41), 
363 (3.30), 362 (4.88; C23H26N2S), 361 (1.98), 349 (4.30; C22H25N2S), 348 (2.40), 
347 (2.50), 332 (2.00), 300 (2.00), 299 (6.00; C,8H23N2S), 295 (2.70), 294 (3.00; 
C,8H,8N2S), 280 (3.42), 279 (12.79; C|7'H|5N2S), 268 (1.81), 266 (2.30), 241 (4.00), 
240 (6.70; C^HizNjS), 231 (10.35; C,5H|,S), 230 (3.52), 225 (1.28), 224 (1.70), 
216 (1.50), 215 (1.70), 202 (1.70), 201 (2.36), 199 (3.50), 180 (3.20), 179 (5.92), 
178 (9.25), 166 (2.85), 165 (2.80), 164 (8.00), 163 (2.54),' 147 (1.50), 146 (5.60), 
144 
145 (10.78), 135 (1.20), 134 (1.35), 131 (2.50), 130 (2.30), 126 (1.50), 124 (1.00), 
123 (5.0; C7H7S), 122 (4.28), 121 (1.50), 107 (2.30), 105 2.50), 103 (4.50), 94 
(7.50), 93 (7.93), 92 (18.00), 88 (3.75), 87 (7.50), 82 (6.50), 79 (10.30), 78 (9.50), 
77 (22.50), 76 (2.50), 68 (4.00), 67 (2.50), 64 (11.00), 57 (2.00), 56 (7.50), 55 
(18.40), 54 (27.50), 44 (9.70), 43 (45.80),41 (23.50). 
2'-ainino-5a"Choiest-6-eno f6,7-d1 thiazole (IV) 
MS, M-^ 442 (100.00; C28H46N2S), 427 (12.50; C27H43N2S), 420 (5.00) 410 (2.50), 
400 (2.5; C27H44S), 395 (3.75), 388(5.00), 387 (36.25), 386(85.50; C24H38N2S), 385 
(8.75; C24H37N2S), 384 (100.00; C28H46N2S), 372 (7.5), 371(18.75), 370 (2.5), 
369(5.00), 368(3.75), 332 (5.00), 329 (5.00; C20H29N2S), 302 (2.94; C18H26N2S), 
301 (3.75; C,8H25>^2S), 269 (3.00), 295 (2.5), 275 (4.20), 274 (U.25), 273 (43.75; 
C16H21N2S), 263 (5.00), 246 (7.50; C14H18N2S), 245 (7.50), 244 (4.50), 233 (14.00), 
232 (23.14), 231 (72.50; C.sHigS), 220 (6.25), 218 (2.50), 216 (8.75; CuHieS), 205 
(3.75), 204 (2.50), 203 (5.00), 190 (2.50), 189 (5.00), 178 (2.50), 177 (11.25), 176 
(2.5), 165 (7.5), 164 (12.50; C8HgN2S), 163 (10.00; C8H7N2S), 161 (2.50), 152 
(7.50), 150 (6.25), 149 (16.25; C7H5N2S), 147 (5.00), 137 (7.5), 136 (17.50), 135 
(15.00), 124 (6.25), 123 (32.50; C7H7S), 122 (16.25), 121 (10.00), 119 (6.25), 110 
(5.00), 108 (27.50), 107 (27.5), 105 (12.50), 91 (16.25), 83 (10.00), 82 (11.25), 80 
(7.5), 79 (27.5), 77 (10.00), 71 (15.00), 70 (7.50), 69 (25.00), 68 (15.00), 67 
(30.00), 57 (30.00), 56 (15.00), 55 (45.00), 53 (10.00), 44 (12.50), 43 (95.00), 41 
(50.00). 
3B-Acetoxv-2'-aniino-5a-cholest-6-eno f6,7-d1 thiazole (V) 
MS, M-^ 500 (100.00; C30H48N2SO2), m/z 485 (3.75; C2c,H45N2S02), 441 (2.50), 440 
(6.25; C28H44N2S), 426 (2.50), 425 (12.50; C27H41N2S), 409 (2.50), 400 (2.50), 398 
(3.75; C27H42S), 391 (5.00), 387(15.00; C22H3,N2S04), 386 (8.20; C24H38N2S), 384 
(3.00), 360(2.50), 327 (12.00; C20H27N2S), 300 (2.80; C,8H24N2S), 292 (2.50), 291 
(10.00), 273 (2.80; C,6H2,N2S), 246 (4.10; CuH.gNjS), 231 (39.00; CisH.gS), 220 
(2.50), 219 (2.50), 218 (12.50), 202 (5.00), 191 (2.50), 189 (12.50), 176 (2.50), 165 
(2.50), 164 (3.00; C8H,8N2S), 163 (2.50; C8H17N2S), 15T (2.50), 149 (5.00; 
C7H5N2S), 136 (2.50), 134 (2.50), 124 (1.80), 123 (26.00; C7H7S), 119 (2.90), 109 
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(2.50), 107 (2.50), 95 (3.75), 94 (2.50), 93 (10.00), 90 (2.50), 83 (1.25), 81 (3.75), 
79 (1.25), 71 (2.50), 68 (2.50), 66 (3.75), 57 (6.25), 56 (2.50), 55 (10.00), 43 
(40.00), 42 (2.50), 41 (13.75). 
3B- proponoxy -2'-aniino-5a-cholest-6-eno f6,7-d1 thaizole (VI) 
M ^ 514 (100.00; CsiHsoNzSOz), 499 (4.00; C30H47SO2), 474 (1.50), 473 (2.01), 463 
(3.00), 462 (2.04), 441 (2.50), 440 (6.25; C28H44N2S), 425 (4.00), 402 (1.08), 401 
(2.50; C23H33N2SO2), 400 (1.50), 399 (2.06), 398 (4.00; C27H42S), 388 (2.50), 387 
(1.50), 386 (4.00; C24H38N2S), 385 (2.00), 374 (2.02; C21H30N2SO2), 373 (7.00; 
C2,H29N2S02), 372 (1.00), 332 (3.00), 331 (1.50), 301 (5.00), 300 (10.00; 
C18H24N2S), 291 (1.80), 289 (4.00), 275 (2.50), 274 (2.00), 273 (5.50; CioHjiN.S), 
272 (2.01), 246 (3.50), 245 (I.OO), 232 (3.23), 231 (3.00; C|5H,9S), 219 (1.50), 218 
(1.80), 204 (2.00), 203 (4.50), 189 (2.00), 188 (2.40), 165 (1.00), 164 (5.00; 
C8H|gN2S), 163 (2.50; C8H17N2S), 150 (3.00), 149 (8.00; C7i-lsS), 146 (3.50), 145 
(7.50), 137 (8.00), 136 (5.00), 135 (10.50), 125 (6.30), 124 (7.00), 123 (30.50; 
C7H7S), 121 (2.50), 119 (10.00), 118 (5.00), 110 (11.00), 109 (6.00),96 (1.00),95 
(3.50), 92 (2.07), 91 (2.40), 90 (5.00), 86 (1.00), 83 (7.50), 82 (15.00), 81 (2.80), 80 
(17.40), 76 (6.50), 73 (6.06), 68 (4.30), 67 (6.20), 66 (10.00), 56 (10.09), 55 (23.20), 
54 (34.00), 44 (2.70), 43 (48.30), 41 (18.00). 
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